Respiratory Care Devices Market by Product (Therapeutic (CPAP, Ventilator, Nebulizer, Inhaler), Pulse Oximeter, Spirometer), Indication, End User, Key stakeholders & Expectations, Unmet needs, Buying Criteria, Reimbursement - Global Forecast to 2028
The global respiratory care devices market is projected to reach USD 31.8 billion by 2028 from USD 21.8 billion in 2023, at a CAGR of 7.8%. Rising prevalence of respiratory diseases as a result of the rapid growth in the global geriatric population will drive the market growth.
COPD and asthma are the most prevalent respiratory disorders across the globe. As per the WHO, COPD is the third leading cause of death worldwide, causing 3.2 million deaths in 2019. More than 80% of these deaths have occurred in low and middle-income countries. Over 380 million people globally are anticipated to have COPD. Largely undiagnosed COPD patients are high in regions and countries, such as China, India, Brazil, and Eastern Europe. The cost incurred to healthcare systems for COPD across the globe is nearly USD 50 billion annually. Some of the major causes of COPD are long-term asthma and prolonged exposure to tobacco smoke, indoor & outdoor air pollution, and occupational fumes & dust. Other comorbid chronic conditions, including cardiovascular disease, musculoskeletal impairment, and diabetes mellitus, are related to COPD. These conditions may also impact the health status of patients, as well as interfere with COPD management.
“The ventilators segment holds the major share of the therapeutic respiratory care devices market”
The therapeutic respiratory care devices market is segmented into ventilators, positive airway pressure (PAP) devices, humidifiers, nebulizers, oxygen concentrators, reusable resuscitators, inhalers, masks, nitric oxide delivery units, and oxygen hoods. In 2022, the ventilators segment holds the major share of the therapeutic respiratory care devices market. A large share of the ventilator segment can be attributed to the rising number of intensive care beds equipped with ventilators, increasing ICU admission and re-admissions in developed countries, and the favorable reimbursement scenario.
“The COPD segment holds the major share of the respiratory care devices market”
By disease indiation the respiratory care devices market is segmented into chronic obstructive pulmonary disease (COPD), asthma, sleep apnea, infectious diseases, and other disease indications. The COPD segment holds the major share of the respiratory care devices market. A large share of the COPD segment can be attributed to the tobacco smoking, genetic disorders, and the increasing geriatric population. The high prevalence of COPD and the growing number of deaths caused by COPD are expected to drive the demand for respiratory care devices during the forecast period.
“The hospitals segment holds the major share of the respiratory care devices market”
By end user the respiratory care devices market is segmented into hospitals, home care settings, ambulatory care centers (ACCs), and other end users. The hospitals segment holds the major share of the respiratory care devices market. A large share of the hospitals segment can be attributed to the financial capabilities of hospitals to purchase expensive equipment and the availability of trained professionals in hospitals to operate respiratory care devices. Additionally, the trend of economic expansion and government focus on broader welfare policies has led to the growth of the healthcare sector in emerging economies.
“Asia Pacific will grow at highest CAGR during the forecast period”
In 2022, Asia Pacific will grow at highest CAGR during the forecast period. The high growth in this market can majorly be attributed to the to high-growth markets such as Japan, China, India, South Korea, Taiwan, Australia, and Singapore. In these countries, the rising geriatric population, growing per capita income, increasing investments in the healthcare industry by key market players.
“Improved profitability & mobility and enhanced remote moitoring–unmet needs in the respiratory care devices market”
Research Coverage:
The report analyzes the respiratory care devices market and aims at estimating the market size and future growth potential of this market based on various segments such as product, disease indication, end user and region. The report also includes a product portfolio matrix of various respiratory care devices available in the market. The report also provides a competitive analysis of the key players in this market, along with their company profiles, product, and key market strategies.
Reasons to Buy the Report
The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall respiratory care devices market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and to plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report provides insights into the following pointers:
COPD and asthma are the most prevalent respiratory disorders across the globe. As per the WHO, COPD is the third leading cause of death worldwide, causing 3.2 million deaths in 2019. More than 80% of these deaths have occurred in low and middle-income countries. Over 380 million people globally are anticipated to have COPD. Largely undiagnosed COPD patients are high in regions and countries, such as China, India, Brazil, and Eastern Europe. The cost incurred to healthcare systems for COPD across the globe is nearly USD 50 billion annually. Some of the major causes of COPD are long-term asthma and prolonged exposure to tobacco smoke, indoor & outdoor air pollution, and occupational fumes & dust. Other comorbid chronic conditions, including cardiovascular disease, musculoskeletal impairment, and diabetes mellitus, are related to COPD. These conditions may also impact the health status of patients, as well as interfere with COPD management.
“The ventilators segment holds the major share of the therapeutic respiratory care devices market”
The therapeutic respiratory care devices market is segmented into ventilators, positive airway pressure (PAP) devices, humidifiers, nebulizers, oxygen concentrators, reusable resuscitators, inhalers, masks, nitric oxide delivery units, and oxygen hoods. In 2022, the ventilators segment holds the major share of the therapeutic respiratory care devices market. A large share of the ventilator segment can be attributed to the rising number of intensive care beds equipped with ventilators, increasing ICU admission and re-admissions in developed countries, and the favorable reimbursement scenario.
“The COPD segment holds the major share of the respiratory care devices market”
By disease indiation the respiratory care devices market is segmented into chronic obstructive pulmonary disease (COPD), asthma, sleep apnea, infectious diseases, and other disease indications. The COPD segment holds the major share of the respiratory care devices market. A large share of the COPD segment can be attributed to the tobacco smoking, genetic disorders, and the increasing geriatric population. The high prevalence of COPD and the growing number of deaths caused by COPD are expected to drive the demand for respiratory care devices during the forecast period.
“The hospitals segment holds the major share of the respiratory care devices market”
By end user the respiratory care devices market is segmented into hospitals, home care settings, ambulatory care centers (ACCs), and other end users. The hospitals segment holds the major share of the respiratory care devices market. A large share of the hospitals segment can be attributed to the financial capabilities of hospitals to purchase expensive equipment and the availability of trained professionals in hospitals to operate respiratory care devices. Additionally, the trend of economic expansion and government focus on broader welfare policies has led to the growth of the healthcare sector in emerging economies.
“Asia Pacific will grow at highest CAGR during the forecast period”
In 2022, Asia Pacific will grow at highest CAGR during the forecast period. The high growth in this market can majorly be attributed to the to high-growth markets such as Japan, China, India, South Korea, Taiwan, Australia, and Singapore. In these countries, the rising geriatric population, growing per capita income, increasing investments in the healthcare industry by key market players.
“Improved profitability & mobility and enhanced remote moitoring–unmet needs in the respiratory care devices market”
- Many respiratory patients need oxygen therapy but require more lightweight, compact devices for increased mobility. Currently available portable devices may not fully meet this need.
- There's a growing demand for remote patient monitoring to reduce hospital admissions and improve patient outcomes. However, existing solutions may lack full integration or real-time data transmission.
- By Company Type: Tier 1 – 35%, Tier 2 – 40%, and Tier 3 – 25%
- By Designation: C Level – 20%, Director Level – 35%, Others-45%
- By Region: North America – 30%, Europe – 27%, Asia Pacific – 25%, Middle East – 10%, and Latin America – 8%
- By End User: Hospitals- 47%, Home Care- 33%, Others-20%
- By Designation: Doctors-35%, Diagnostic Centre Lab Heads-27%, Hospital Directors & Managers-22%, Others-16%
- By Region: North America-34%, Europe-22%, Asia Pacific-20%, Latin America-16%, Middle East & Africa-8%
Research Coverage:
The report analyzes the respiratory care devices market and aims at estimating the market size and future growth potential of this market based on various segments such as product, disease indication, end user and region. The report also includes a product portfolio matrix of various respiratory care devices available in the market. The report also provides a competitive analysis of the key players in this market, along with their company profiles, product, and key market strategies.
Reasons to Buy the Report
The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall respiratory care devices market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and to plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report provides insights into the following pointers:
- Analysis of key drivers (Rising Prevalence of Respiratory Diseases, Increasing incidence rate of preterm births, Outbreak of infectious diseases affecting the respiratory system, Underpenetrated markets in sleep and COPD, Focus on improving patient outcomes, Rising R&D investments resulting in technologically advanced devices), restraints (Unfavorable reimbursement scenario, Availability of low-cost products from local manufacturers, High cost of CPAP machines), opportunities (Growing demand for home care therapeutic devices, High growth in developing countries, Point-of-care Diagnostics, Growing awareness about the ill-effects of untreated sleep apnea), and challenges (Low awareness and a large underdiagnosed and undertreated population, Harmful effects of certain devices on neonates)
- Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the respiratory care devices market
- Market Development: Comprehensive information on the lucrative emerging markets by product, disease indication, end user and region.
- Market Diversification: Exhaustive information about new products or product enhancements, growing geographies, recent developments, and investments in the global respiratory care devices market.
- Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, competitive leadership mapping, and capabilities of leading players like Koninklijke Philips N.V. (Netherlands), General Electric Healthcare (US), ResMed Inc. (US), Fisher & Paykel Healthcare Corporation Limited (New Zealand), and Medtronic plc (Ireland) in the global respiratory care devices market.
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS AND EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
FIGURE 1 RESPIRATORY CARE DEVICES MARKET SEGMENTATION
FIGURE 2 RESPIRATORY CARE DEVICES MARKET, BY REGION
1.3.2 YEARS CONSIDERED
1.4 CURRENCY CONSIDERED
TABLE 1 ANNUAL AVERAGE EXCHANGE RATE FOR CURRENCY CONVERSION, 2018–2022
1.5 STAKEHOLDERS
1.6 LIMITATIONS
1.7 SUMMARY OF CHANGES
1.8 RECESSION IMPACT
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
FIGURE 3 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
FIGURE 4 PRIMARY SOURCES
2.1.2.1 Key data from primary sources
2.1.2.2 Key industry insights
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 7 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION
2.2 MARKET SIZE ESTIMATION
FIGURE 8 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
FIGURE 9 REVENUE SHARE ANALYSIS ILLUSTRATION: KONINKLIJKE PHILIPS N.V.
FIGURE 10 SUPPLY-SIDE MARKET ESTIMATION: RESPIRATORY CARE DEVICES MARKET (2022)
FIGURE 11 DEMAND-SIDE MARKET ESTIMATION: VENTILATORS MARKET (2022)
FIGURE 12 TOTAL MARKET SIZE ESTIMATION: RESPIRATORY CARE DEVICES MARKET
FIGURE 13 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2023–2028)
FIGURE 14 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
FIGURE 15 TOP-DOWN APPROACH
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 16 MARKET DATA TRIANGULATION METHODOLOGY
2.4 STUDY ASSUMPTIONS
2.4.1 MARKET SHARE ASSUMPTIONS
2.4.2 RESEARCH ASSUMPTIONS
2.5 RISK ASSESSMENT
TABLE 2 RESPIRATORY CARE DEVICES MARKET: RISK ASSESSMENT ANALYSIS
2.6 RESEARCH LIMITATIONS
2.7 RECESSION IMPACT ANALYSIS
3 EXECUTIVE SUMMARY
FIGURE 17 RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION)
FIGURE 18 RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2023 VS. 2028 (USD MILLION)
FIGURE 19 RESPIRATORY CARE DEVICES MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
FIGURE 20 RESPIRATORY CARE DEVICES MARKET: GEOGRAPHICAL SNAPSHOT
4 PREMIUM INSIGHTS
4.1 RESPIRATORY CARE DEVICES MARKET OVERVIEW
FIGURE 21 HIGH TOBACCO CONSUMPTION TO BOOST MARKET GROWTH THROUGHOUT FORECAST PERIOD
4.2 NORTH AMERICA: RESPIRATORY CARE DEVICES MARKET, BY TYPE (2022)
FIGURE 22 THERAPEUTIC RESPIRATORY CARE DEVICES ACCOUNTED FOR LARGEST MARKET SHARE IN 2022
4.3 RESPIRATORY CARE DEVICES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 23 INDIA TO DISPLAY HIGHEST CAGR DURING FORECAST PERIOD
4.4 RESPIRATORY CARE DEVICES MARKET: REGIONAL MIX
FIGURE 24 NORTH AMERICA TO CONTINUE TO DOMINATE MARKET THROUGHOUT FORECAST PERIOD
4.5 RESPIRATORY CARE DEVICES MARKET: DEVELOPED VS. EMERGING ECONOMIES
FIGURE 25 EMERGING ECONOMIES TO REGISTER HIGHER CAGRS DURING FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 26 RESPIRATORY CARE DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Rising prevalence of respiratory diseases
5.2.1.1.1 Rapid growth in global geriatric population
FIGURE 27 GLOBAL GERIATRIC POPULATION, BY REGION
5.2.1.1.2 Urbanization and growing pollution levels
FIGURE 28 ANNUAL DATA OF DEATHS CAUSED BY HOUSEHOLD AND AMBIENT AIR POLLUTION, BY DISEASE
5.2.1.1.3 Growing tobacco consumption
TABLE 3 REGION-WISE DATA ON LIFESTYLE DISEASES
5.2.1.1.4 Increased adoption of sedentary lifestyles
5.2.1.2 Surging incidence rate of preterm births
TABLE 4 TOP 10 COUNTRIES WITH HIGHEST NUMBER OF PRETERM BIRTHS
TABLE 5 TOP 10 COUNTRIES WITH HIGHEST RATES OF PRETERM BIRTH PER 100 LIVE BIRTHS
5.2.1.3 Growing outbreaks of infectious diseases affecting respiratory systems
5.2.1.4 Rising population with sleep disorders
5.2.1.5 Improved patient outcomes using respiratory care devices
5.2.1.6 Surging R&D investments for technological advancement of medical devices
TABLE 6 PRODUCT LAUNCHES
5.2.2 RESTRAINTS
5.2.2.1 Unfavorable reimbursement scenario for respiratory care diagnostics
5.2.2.2 Availability of low-cost products from local manufacturers
5.2.2.3 High cost of CPAP machines
5.2.3 OPPORTUNITIES
5.2.3.1 Growing demand for home care therapeutic devices
5.2.3.2 Market growth opportunities in Asia Pacific and Latin America
5.2.3.3 Increasing preference for self-testing
5.2.3.4 Growing awareness about ill effects of untreated sleep apnea
TABLE 7 INITIATIVES TO PROMOTE AWARENESS ABOUT UNTREATED SLEEP APNEA
5.2.4 CHALLENGES
5.2.4.1 Low awareness and lack of diagnosis of respiratory diseases
5.2.4.2 Harmful effects of certain respiratory care devices on neonates
5.2.4.3 Lack of patient compliance with CPAP therapy
5.3 INDUSTRY TRENDS
5.3.1 RISING DEMAND FOR ENHANCED COMPACT AND PORTABLE DEVICES
5.3.2 KEY FOCUS OF MARKET PLAYERS ON GEOGRAPHICAL EXPANSION
5.3.3 GROWING DEMAND FOR MULTIMODAL VENTILATION
5.3.4 RISING ADOPTION OF NON-INVASIVE VENTILATION
FIGURE 29 IMPACT OF INNOVATIVE SOLUTIONS
FIGURE 30 INTRODUCTION OF INNOVATIVE SOLUTIONS FOR SLEEP APNEA TREATMENT
5.4 REGULATORY ANALYSIS
5.4.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 8 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 9 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 10 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.4.2 NORTH AMERICA
5.4.2.1 US
TABLE 11 US: CLASSIFICATION OF MEDICAL EQUIPMENT
TABLE 12 US: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
5.4.2.2 Canada
TABLE 13 CANADA: LEVEL OF RISK, TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
5.4.3 EUROPE
TABLE 14 EUROPE: LEVEL OF RISK, TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
5.4.4 ASIA PACIFIC
5.4.4.1 Japan
TABLE 15 JAPAN: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
5.4.4.2 China
TABLE 16 CHINA: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
5.4.4.3 India
5.5 ECOSYSTEM ANALYSIS
FIGURE 31 RESPIRATORY CARE DEVICES MARKET: ECOSYSTEM ANALYSIS
5.6 VALUE CHAIN ANALYSIS
FIGURE 32 RESPIRATORY CARE DEVICES MARKET: VALUE CHAIN ANALYSIS
5.7 IMPACT OF COVID-19 ON RESPIRATORY CARE DEVICES MARKET
5.8 TECHNOLOGY ANALYSIS
5.8.1 E-NOSE TECHNOLOGY
5.8.2 MEMS TECHNOLOGY
5.8.3 ELECTROCHEMICAL TECHNOLOGY
5.8.4 WIRELESS GAS SENSOR TECHNOLOGY
5.9 PATENT ANALYSIS
5.9.1 PATENT PUBLICATION TRENDS FOR RESPIRATORY CARE DEVICES
FIGURE 33 PATENT PUBLICATION TRENDS (2015–2023)
5.9.2 TOP APPLICANTS FOR RESPIRATORY CARE DEVICE PATENTS, BY GEOGRAPHY (2015–2023)
TABLE 17 TOP APPLICANTS FOR RESPIRATORY CARE DEVICE PATENTS, BY GEOGRAPHY
5.9.3 RESPIRATORY CARE DEVICES MARKET: TOP APPLICANTS
FIGURE 34 TOP APPLICANTS FOR RESPIRATORY CARE DEVICES PATENTS (2015–2023)
5.10 TRADE ANALYSIS
TABLE 18 TOP EXPORTERS OF MEDICAL VENTILATORS, CPAP, BIPAP, AND OXYGEN CONCENTRATORS, 2021
5.11 CASE STUDY ANALYSIS
TABLE 19 REPLACEMENT PATTERN OF VENTILATORS: DEVELOPED ECONOMIES VS. EMERGING ECONOMIES
TABLE 20 VOLUME DATA OF VENTILATORS, ICU VENTILATORS, PORTABLE VENTILATORS, PAP DEVICES, CPAP DEVICES, BIPAP DEVICES, AND SPIROMETERS
5.12 PORTER’S FIVE FORCES ANALYSIS
TABLE 21 PORTER’S FIVE FORCES ANALYSIS
5.12.1 THREAT OF NEW ENTRANTS
5.12.2 THREAT OF SUBSTITUTES
5.12.3 BARGAINING POWER OF SUPPLIERS
5.12.4 BARGAINING POWER OF BUYERS
5.12.5 INTENSITY OF COMPETITIVE RIVALRY
5.13 KEY CONFERENCES AND EVENTS, 2023–2024
5.13.1 RESPIRATORY CARE DEVICES MARKET: LIST OF KEY CONFERENCES AND EVENTS
5.14 KEY STAKEHOLDERS AND BUYING CRITERIA
5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS
TABLE 22 STAKEHOLDERS IN BUYING PROCESS FOR RESPIRATORY CARE DEVICES
TABLE 23 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR RESPIRATORY CARE DEVICES
5.14.2 BUYING CRITERIA
FIGURE 35 KEY BUYING CRITERIA FOR RESPIRATORY DEVICES
TABLE 24 KEY BUYING CRITERIA FOR RESPIRATORY CARE DEVICES
5.15 PRICING ANALYSIS
TABLE 25 AVERAGE SELLING PRICE OF RESPIRATORY CARE DEVICES
5.16 UNMET NEEDS PERTAINING TO RESPIRATORY CARE DEVICES
TABLE 26 RESPIRATORY CARE DEVICES MARKET: UNMET NEEDS
5.16.1 END USER EXPECTATIONS
TABLE 27 RESPIRATORY CARE DEVICES MARKET: END USER EXPECTATIONS
5.17 APPLICATION OF ARTIFICIAL INTELLIGENCE IN RESPIRATORY CARE DEVICES
TABLE 28 RESPIRATORY CARE DEVICES MARKET: APPLICATION OF ARTIFICIAL INTELLIGENCE
5.17.1 FUTURE OF HEALTHCARE—BIG DATA AND ARTIFICIAL INTELLIGENCE
5.18 REIMBURSEMENT SCENARIO
TABLE 29 RESPIRATORY CARE DEVICES MARKET: REIMBURSEMENT SCENARIO
6 RESPIRATORY CARE DEVICES MARKET, BY PRODUCT
6.1 INTRODUCTION
TABLE 30 RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 31 RESPIRATORY CARE DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.2 THERAPEUTIC RESPIRATORY CARE DEVICES
TABLE 32 THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 33 THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.2.1 PAP DEVICES
TABLE 34 PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 35 PAP DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 36 PAP DEVICES MARKET, BY REGION, 2021–2028 (THOUSAND UNITS)
6.2.1.1 CPAP devices
6.2.1.1.1 Growing popularity of nasal CPAP therapies to drive demand
TABLE 37 MAJOR PLAYERS OFFERING CPAP DEVICES IN MARKET
TABLE 38 CPAP DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 39 CPAP DEVICES MARKET, BY REGION, 2021–2028 (THOUSAND UNITS)
6.2.1.2 APAP devices
6.2.1.2.1 Rising awareness among sleep specialists and patients regarding additional features of APAP devices to boost market
TABLE 40 MAJOR PLAYERS OFFERING APAP DEVICES IN MARKET
TABLE 41 APAP DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 42 APAP DEVICES MARKET, BY REGION, 2021–2028 (THOUSAND UNITS)
6.2.1.3 BiPAP devices
6.2.1.3.1 Increasing number of hospitals to strengthen market
TABLE 43 MAJOR PLAYERS OFFERING BIPAP DEVICES IN MARKET
TABLE 44 BIPAP DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 45 BIPAP DEVICES MARKET, BY REGION, 2021–2028 (THOUSAND UNITS)
6.2.2 VENTILATORS
TABLE 46 VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 47 VENTILATORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 48 VENTILATORS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS)
6.2.2.1 ICU ventilators
TABLE 49 MAJOR PLAYERS OFFERING ICU VENTILATORS IN MARKET
TABLE 50 ICU VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 51 ICU VENTILATORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 52 ICU VENTILATORS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS)
6.2.2.1.1 High-end ventilators
6.2.2.1.1.1 Improving healthcare infrastructure and rising healthcare expenditure to drive market
TABLE 53 HIGH-END VENTILATORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 54 HIGH-END VENTILATORS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS)
6.2.2.1.2 Mid-end ventilators
6.2.2.1.2.1 Better affordability and accessibility of mid-end ventilators than high-end models to support market growth
TABLE 55 MID-END VENTILATORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 56 MID-END VENTILATORS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS)
6.2.2.1.3 Basic ventilators
6.2.2.1.3.1 Expanding access to critical healthcare facilities in developing countries to spur demand
TABLE 57 BASIC VENTILATORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 58 BASIC VENTILATORS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS)
6.2.2.2 Portable/Transportable ventilators
6.2.2.2.1 Increasing demand for home care to boost segmental growth
TABLE 59 MAJOR PLAYERS OFFERING PORTABLE/TRANSPORTABLE VENTILATORS IN MARKET
TABLE 60 PORTABLE/TRANSPORTABLE VENTILATORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 61 PORTABLE/TRANSPORTABLE VENTILATORS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS)
6.2.3 NEBULIZERS
TABLE 62 MAJOR PLAYERS OFFERING NEBULIZERS IN MARKET
TABLE 63 NEBULIZERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 64 NEBULIZERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 65 NEBULIZERS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS)
6.2.3.1 Jet nebulizers
6.2.3.1.1 Increasing prevalence of respiratory conditions to augment market size
TABLE 66 JET NEBULIZERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 67 JET NEBULIZERS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS)
6.2.3.2 Mesh nebulizers
6.2.3.2.1 Deployment of advanced aerosolization technology to drive market
TABLE 68 MESH NEBULIZERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 69 MESH NEBULIZERS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS)
6.2.3.3 Ultrasonic nebulizers
6.2.3.3.1 Adjustable settings for particle size and treatment duration to boost market
TABLE 70 ULTRASONIC NEBULIZERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 71 ULTRASONIC NEBULIZERS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS)
6.2.4 HUMIDIFIERS
TABLE 72 HUMIDIFIERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 73 HUMIDIFIERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 74 HUMIDIFIERS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS)
6.2.4.1 Heated humidifiers
6.2.4.1.1 Ease of control and customizability to grow market
TABLE 75 MAJOR PLAYERS OFFERING HEATED HUMIDIFIERS IN MARKET
TABLE 76 HEATED HUMIDIFIERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 77 HEATED HUMIDIFIERS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS)
6.2.4.2 Passover humidifiers
6.2.4.2.1 Minimal maintenance and simple technology to spur demand
TABLE 78 MAJOR PLAYERS OFFERING PASSOVER HUMIDIFIERS IN MARKET
TABLE 79 PASSOVER HUMIDIFIERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 80 PASSOVER HUMIDIFIERS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS)
6.2.5 OXYGEN CONCENTRATORS
TABLE 81 MAJOR PLAYERS OFFERING OXYGEN CONCENTRATORS IN MARKET
TABLE 82 OXYGEN CONCENTRATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 83 OXYGEN CONCENTRATORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 84 OXYGEN CONCENTRATORS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS)
6.2.5.1 Fixed oxygen concentrators
6.2.5.1.1 Better access to healthcare services to grow demand
TABLE 85 FIXED OXYGEN CONCENTRATORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 86 FIXED OXYGEN CONCENTRATORS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS)
6.2.5.2 Portable oxygen concentrators
6.2.5.2.1 Low weight and easy setup to drive segmental growth
TABLE 87 PORTABLE OXYGEN CONCENTRATORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 88 PORTABLE OXYGEN CONCENTRATORS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS)
6.2.6 INHALERS
TABLE 89 INHALERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 90 INHALERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 91 INHALERS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS)
6.2.6.1 Metered-dose inhalers (MDIs)
6.2.6.1.1 Ongoing advancements in MDI technology to support market growth
TABLE 92 METERED-DOSE INHALERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 93 METERED-DOSE INHALERS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS)
6.2.6.2 Dry powder inhalers (DPIs)
6.2.6.2.1 Developments in particle engineering and powder formulations to boost segmental growth
TABLE 94 DRY POWDER INHALERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 95 DRY POWDER INHALERS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS)
6.2.7 REUSABLE RESUSCITATORS
6.2.7.1 Disposable and reusable nature to drive demand
TABLE 96 MAJOR PLAYERS OFFERING REUSABLE RESUSCITATORS IN MARKET
TABLE 97 REUSABLE RESUSCITATORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 98 REUSABLE RESUSCITATORS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS)
6.2.8 NITRIC OXIDE DELIVERY UNITS
6.2.8.1 Rising emphasis of companies on developing innovative and advanced nitric oxide delivery units to drive market
TABLE 99 MAJOR PLAYERS OFFERING NITRIC OXIDE DELIVERY UNITS IN MARKET
TABLE 100 NITRIC OXIDE DELIVERY UNITS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 101 NITRIC OXIDE DELIVERY UNITS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS)
6.2.9 OXYGEN HOODS
6.2.9.1 Growing prevalence of respiratory diseases in kids to drive market growth
TABLE 102 MAJOR PLAYERS OFFERING OXYGEN HOODS IN MARKET
TABLE 103 OXYGEN HOODS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 104 OXYGEN HOODS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS)
6.3 MONITORING DEVICES
TABLE 105 RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 106 RESPIRATORY CARE MONITORING DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.3.1 PULSE OXIMETERS
TABLE 107 MAJOR PLAYERS OFFERING PULSE OXIMETERS IN MARKET
TABLE 108 PULSE OXIMETERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 109 PULSE OXIMETERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 110 PULSE OXIMETERS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS)
6.3.1.1 Pulse oximeter sensors
6.3.1.1.1 Development of advanced sensors with embedded chips to boost segmental growth
TABLE 111 PULSE OXIMETER SENSORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 112 PULSE OXIMETER SENSORS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS)
6.3.1.2 Pulse oximeter equipment
6.3.1.2.1 Growing prevalence of chronic respiratory conditions to boost demand
TABLE 113 MAJOR PLAYERS OFFERING PULSE OXIMETER EQUIPMENT IN MARKET
TABLE 114 PULSE OXIMETER EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 115 PULSE OXIMETER EQUIPMENT MARKET, BY REGION, 2021–2028 (THOUSAND UNITS)
6.3.2 CAPNOGRAPHS
6.3.2.1 Ongoing R&D on capnographs to offer lucrative growth opportunities
TABLE 116 MAJOR PLAYERS OFFERING CAPNOGRAPHS IN MARKET
TABLE 117 CAPNOGRAPHS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 118 CAPNOGRAPHS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS)
6.3.3 GAS ANALYZERS
6.3.3.1 Increasing demand for point-of-care testing to drive demand
TABLE 119 MAJOR PLAYERS OFFERING GAS ANALYZERS IN MARKET
TABLE 120 GAS ANALYZERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 121 GAS ANALYZERS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS)
6.4 DIAGNOSTIC RESPIRATORY CARE DEVICES
TABLE 122 DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 123 DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.4.1 SPIROMETERS
6.4.1.1 Rising technological advancements in spirometers to support market growth
TABLE 124 MAJOR PLAYERS OFFERING SPIROMETERS IN MARKET
TABLE 125 SPIROMETERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 126 SPIROMETERS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS)
6.4.2 POLYSOMNOGRAPHY DEVICES (PSG DEVICES)
6.4.2.1 Rising incidence of obstructive sleep apnea to drive demand
TABLE 127 MAJOR PLAYERS OFFERING POLYSOMNOGRAPHY DEVICES IN MARKET
TABLE 128 POLYSOMNOGRAPHY DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 129 POLYSOMNOGRAPHY DEVICES MARKET, BY REGION, 2021–2028 (THOUSAND UNITS)
6.4.3 PEAK FLOW METERS
6.4.3.1 Low-cost and uncomplicated nature to drive segmental growth
TABLE 130 MAJOR PLAYERS OFFERING PEAK FLOW METERS IN MARKET
TABLE 131 PEAK FLOW METERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 132 PEAK FLOW METERS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS)
6.4.4 OTHER DIAGNOSTIC DEVICES
TABLE 133 OTHER DIAGNOSTIC DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.5 CONSUMABLES & ACCESSORIES
TABLE 134 RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 135 RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.5.1 MASKS
TABLE 136 MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 137 MASKS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.5.1.1 Reusable masks
6.5.1.1.1 Growing concerns related to air pollution to grow demand
TABLE 138 REUSABLE MASKS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.5.1.2 Disposable masks
6.5.1.2.1 Stringent government mandates on wearing masks to spur demand
TABLE 139 DISPOSABLE MASKS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.5.2 DISPOSABLE RESUSCITATORS
6.5.2.1 Growing focus on reducing cross-contamination cases in patients to foster segmental growth
TABLE 140 DISPOSABLE RESUSCITATORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.5.3 TRACHEOSTOMY TUBES
6.5.3.1 Introduction of new and advanced products with ergonomic designs to drive market growth
TABLE 141 TRACHEOSTOMY TUBES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.5.4 BREATHING CIRCUITS
6.5.4.1 Healthcare professionals’ efforts to improve infection control practices to grow demand
TABLE 142 BREATHING CIRCUITS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.5.5 NASAL CANNULAE
6.5.5.1 Increasing focus on minimally invasive surgery techniques to fuel demand
TABLE 143 NASAL CANNULAE MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.5.6 OTHER CONSUMABLES & ACCESSORIES
TABLE 144 OTHER CONSUMABLES & ACCESSORIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
7 RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION
7.1 INTRODUCTION
TABLE 145 RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2021–2028 (USD MILLION)
7.2 CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
7.2.1 RISING INDOOR AND OUTDOOR AIR POLLUTION LEVELS TO DRIVE MARKET
TABLE 146 RESPIRATORY CARE DEVICES MARKET FOR COPD, BY COUNTRY, 2021–2028 (USD MILLION)
7.3 SLEEP APNEA
7.3.1 GROWING INCIDENCE OF OBESITY AND CARDIOVASCULAR DISEASES TO FAVOR MARKET GROWTH
TABLE 147 COUNTRY-WISE DATA ON SLEEP APNEA PATIENTS
TABLE 148 RESPIRATORY CARE DEVICES MARKET FOR SLEEP APNEA, BY COUNTRY, 2021–2028 (USD MILLION)
7.4 ASTHMA
7.4.1 INCREASING INCIDENCE OF COPD TO DRIVE MARKET
TABLE 149 RESPIRATORY CARE DEVICES MARKET FOR ASTHMA, BY COUNTRY, 2021–2028 (USD MILLION)
7.5 INFECTIOUS DISEASES
7.5.1 GROWING NUMBER OF TB PATIENTS TO BOOST MARKET GROWTH
TABLE 150 INCIDENCE OF TB (RATE PER 100,000 POPULATION)
TABLE 151 RESPIRATORY CARE DEVICES MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2021–2028 (USD MILLION)
7.6 OTHER DISEASE INDICATIONS
TABLE 152 RESPIRATORY CARE DEVICES MARKET FOR OTHER DISEASE INDICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
8 RESPIRATORY CARE DEVICES MARKET, BY END USER
8.1 INTRODUCTION
TABLE 153 RESPIRATORY CARE DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)
8.2 HOSPITALS
8.2.1 GROWING NUMBER OF HOSPITALS IN EMERGING ECONOMIES TO DRIVE MARKET
TABLE 154 RESPIRATORY CARE DEVICES MARKET FOR HOSPITALS, BY COUNTRY, 2021–2028 (USD MILLION)
8.3 HOME CARE SETTINGS
8.3.1 INCREASING ACCEPTANCE OF HOME CARE DEVICES BY PATIENTS TO BOOST GROWTH
TABLE 155 RESPIRATORY CARE DEVICES MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2021–2028 (USD MILLION)
8.4 AMBULATORY CARE CENTERS (ACCS)
8.4.1 IMPROVED PATIENT EXPERIENCE IN AMBULATORY CARE CENTERS TO DRIVE MARKET
TABLE 156 RESPIRATORY CARE DEVICES MARKET FOR AMBULATORY CARE CENTERS, BY COUNTRY, 2021–2028 (USD MILLION)
8.5 OTHER END USERS
TABLE 157 RESPIRATORY CARE DEVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION)
9 RESPIRATORY CARE DEVICES MARKET, BY REGION
9.1 INTRODUCTION
FIGURE 36 RESPIRATORY CARE DEVICES MARKET: REGIONAL GROWTH OPPORTUNITIES
TABLE 158 RESPIRATORY CARE DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION)
9.2 NORTH AMERICA
FIGURE 37 NORTH AMERICA: RESPIRATORY CARE DEVICES MARKET SNAPSHOT
TABLE 159 NORTH AMERICA: RESPIRATORY CARE DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 160 NORTH AMERICA: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 161 NORTH AMERICA: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 162 NORTH AMERICA: PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 163 NORTH AMERICA: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 164 NORTH AMERICA: VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 165 NORTH AMERICA: ICU VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 166 NORTH AMERICA: INHALERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 167 NORTH AMERICA: HUMIDIFIERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 168 NORTH AMERICA: NEBULIZERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 169 NORTH AMERICA: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 170 NORTH AMERICA: PULSE OXIMETERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 171 NORTH AMERICA: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 172 NORTH AMERICA: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 173 NORTH AMERICA: MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 174 NORTH AMERICA: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2021–2028 (USD MILLION)
TABLE 175 NORTH AMERICA: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)
9.2.1 NORTH AMERICA: RECESSION IMPACT
9.2.2 US
9.2.2.1 Rapid growth in geriatric population to boost market
TABLE 176 US: KEY MACROINDICATORS
TABLE 177 US: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 178 US: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 179 US: PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 180 US: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 181 US: VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 182 US: ICU VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 183 US: INHALERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 184 US: HUMIDIFIERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 185 US: NEBULIZERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 186 US: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 187 US: PULSE OXIMETERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 188 US: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 189 US: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 190 US: MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 191 US: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2021–2028 (USD MILLION)
TABLE 192 US: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)
9.2.3 CANADA
9.2.3.1 Large pool of undiagnosed patients to drive market
TABLE 193 CANADA: COPD AND ASTHMA STATISTICS (2019 VS. 2020)
TABLE 194 CANADA: KEY MACROINDICATORS
TABLE 195 CANADA: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 196 CANADA: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 197 CANADA: PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 198 CANADA: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 199 CANADA: VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 200 CANADA: ICU VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 201 CANADA: INHALERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 202 CANADA: HUMIDIFIERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 203 CANADA: NEBULIZERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 204 CANADA: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 205 CANADA: PULSE OXIMETERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 206 CANADA: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 207 CANADA: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 208 CANADA: MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 209 CANADA: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2021–2028 (USD MILLION)
TABLE 210 CANADA: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)
9.3 EUROPE
TABLE 211 EUROPE: RESPIRATORY CARE DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 212 EUROPE: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 213 EUROPE: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 214 EUROPE: PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 215 EUROPE: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 216 EUROPE: VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 217 EUROPE: ICU VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 218 EUROPE: INHALERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 219 EUROPE: HUMIDIFIERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 220 EUROPE: NEBULIZER MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 221 EUROPE: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 222 EUROPE: PULSE OXIMETERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 223 EUROPE: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 224 EUROPE: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 225 EUROPE: MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 226 EUROPE: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2021–2028 (USD MILLION)
TABLE 227 EUROPE: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)
9.3.1 EUROPE: RECESSION IMPACT
9.3.2 GERMANY
9.3.2.1 Increasing public healthcare expenditure to foster market growth
TABLE 228 GERMANY: KEY MACROINDICA"
TORS
TABLE 229 GERMANY: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 230 GERMANY: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 231 GERMANY: PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 232 GERMANY: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 233 GERMANY: VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 234 GERMANY: ICU VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 235 GERMANY: INHALERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 236 GERMANY: HUMIDIFIERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 237 GERMANY: NEBULIZERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 238 GERMANY: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 239 GERMANY: PULSE OXIMETERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 240 GERMANY: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 241 GERMANY: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 242 GERMANY: MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 243 GERMANY: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2021–2028 (USD MILLION)
TABLE 244 GERMANY: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)
9.3.3 FRANCE
9.3.3.1 High prevalence of COPD to surge demand
TABLE 245 FRANCE: KEY MACROINDICATORS
TABLE 246 FRANCE: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 247 FRANCE: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 248 FRANCE: PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 249 FRANCE: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 250 FRANCE: VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 251 FRANCE: ICU VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 252 FRANCE: INHALERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 253 FRANCE: HUMIDIFIERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 254 FRANCE: NEBULIZERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 255 FRANCE: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 256 FRANCE: PULSE OXIMETERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 257 FRANCE: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 258 FRANCE: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 259 FRANCE: MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 260 FRANCE: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2021–2028 (USD MILLION)
TABLE 261 FRANCE: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)
9.3.4 UK
9.3.4.1 Growing demand for minimally invasive surgeries to drive market
TABLE 262 UK: KEY MACROINDICATORS
TABLE 263 UK: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 264 UK: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 265 UK: PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 266 UK: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 267 UK: VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 268 UK: ICU VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 269 UK: INHALERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 270 UK: HUMIDIFIERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 271 UK: NEBULIZERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 272 UK: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 273 UK: PULSE OXIMETERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 274 UK: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 275 UK: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 276 UK: MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 277 UK: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2021–2028 (USD MILLION)
TABLE 278 UK: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)
9.3.5 ITALY
9.3.5.1 Growing involvement of private sector in healthcare market to drive market
TABLE 279 ITALY: KEY MACROINDICATORS
TABLE 280 ITALY: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 281 ITALY: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 282 ITALY: PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 283 ITALY: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 284 ITALY: VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 285 ITALY: ICU VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 286 ITALY: INHALERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 287 ITALY: HUMIDIFIERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 288 ITALY: NEBULIZERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 289 ITALY: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 290 ITALY: PULSE OXIMETERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 291 ITALY: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 292 ITALY: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 293 ITALY: MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 294 ITALY: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2021–2028 (USD MILLION)
TABLE 295 ITALY: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)
9.3.6 SPAIN
9.3.6.1 Need to improve healthcare infrastructure due to aging demographic to drive demand
TABLE 296 SPAIN: KEY MACROINDICATORS
TABLE 297 SPAIN: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 298 SPAIN: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 299 SPAIN: PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 300 SPAIN: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 301 SPAIN: VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 302 SPAIN: ICU VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 303 SPAIN: INHALERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 304 SPAIN: HUMIDIFIERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 305 SPAIN: NEBULIZERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 306 SPAIN: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 307 SPAIN: PULSE OXIMETERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 308 SPAIN: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 309 SPAIN: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 310 SPAIN: MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 311 SPAIN: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2021–2028 (USD MILLION)
TABLE 312 SPAIN: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)
9.3.7 REST OF EUROPE
TABLE 313 REST OF EUROPE: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 314 REST OF EUROPE: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 315 REST OF EUROPE: PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 316 REST OF EUROPE: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 317 REST OF EUROPE: VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 318 REST OF EUROPE: ICU VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 319 REST OF EUROPE: INHALERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 320 REST OF EUROPE: HUMIDIFIERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 321 REST OF EUROPE: NEBULIZERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 322 REST OF EUROPE: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 323 REST OF EUROPE: PULSE OXIMETERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 324 REST OF EUROPE: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 325 REST OF EUROPE: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 326 REST OF EUROPE: MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 327 REST OF EUROPE: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2021–2028 (USD MILLION)
TABLE 328 REST OF EUROPE: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)
9.4 ASIA PACIFIC
FIGURE 38 ASIA PACIFIC: RESPIRATORY CARE DEVICES MARKET SNAPSHOT
TABLE 329 ASIA PACIFIC: RESPIRATORY CARE DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 330 ASIA PACIFIC: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 331 ASIA PACIFIC: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 332 ASIA PACIFIC: PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 333 ASIA PACIFIC: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 334 ASIA PACIFIC: VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 335 ASIA PACIFIC: ICU VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 336 ASIA PACIFIC: INHALERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 337 ASIA PACIFIC: HUMIDIFIERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 338 ASIA PACIFIC: NEBULIZERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 339 ASIA PACIFIC: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 340 ASIA PACIFIC: PULSE OXIMETERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 341 ASIA PACIFIC: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 342 ASIA PACIFIC: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 343 ASIA PACIFIC: MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 344 ASIA PACIFIC: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2021–2028 (USD MILLION)
TABLE 345 ASIA PACIFIC: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)
9.4.1 ASIA PACIFIC: RECESSION IMPACT
9.4.2 JAPAN
9.4.2.1 Availability of universal healthcare reimbursement policy to drive market
TABLE 346 JAPAN: KEY MACROINDICATORS
TABLE 347 JAPAN: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 348 JAPAN: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 349 JAPAN: PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 350 JAPAN: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 351 JAPAN: VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 352 JAPAN: ICU VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 353 JAPAN: INHALERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 354 JAPAN: HUMIDIFIERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 355 JAPAN: NEBULIZERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 356 JAPAN: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 357 JAPAN: PULSE OXIMETERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 358 JAPAN: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 359 JAPAN: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 360 JAPAN: MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 361 JAPAN: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2021–2028 (USD MILLION)
TABLE 362 JAPAN: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)
9.4.3 CHINA
9.4.3.1 Initiatives to modernize healthcare system and reimbursement facilities to support market growth
TABLE 363 CHINA: KEY MACROINDICATORS
TABLE 364 CHINA: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 365 CHINA: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 366 CHINA: PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 367 CHINA: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 368 CHINA: VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 369 CHINA: ICU VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 370 CHINA: INHALERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 371 CHINA: HUMIDIFIERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 372 CHINA: NEBULIZERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 373 CHINA: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 374 CHINA: PULSE OXIMETERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 375 CHINA: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 376 CHINA: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 377 CHINA: MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 378 CHINA: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2021–2028 (USD MILLION)
TABLE 379 CHINA: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)
9.4.4 INDIA
9.4.4.1 Increasing focus of global players on domestic market to drive market
TABLE 380 INDIA: KEY MACROINDICATORS
TABLE 381 INDIA: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 382 INDIA: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 383 INDIA: PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 384 INDIA: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 385 INDIA: VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 386 INDIA: ICU VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 387 INDIA: INHALERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 388 INDIA: HUMIDIFIERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 389 INDIA: NEBULIZERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 390 INDIA: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 391 INDIA: PULSE OXIMETERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 392 INDIA: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 393 INDIA: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 394 INDIA: MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 395 INDIA: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2021–2028 (USD MILLION)
TABLE 396 INDIA: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)
9.4.5 AUSTRALIA
9.4.5.1 High prevalence of chronic lung diseases to drive demand
TABLE 397 AUSTRALIA: KEY MACROINDICATORS
TABLE 398 AUSTRALIA: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 399 AUSTRALIA: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 400 AUSTRALIA: PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 401 AUSTRALIA: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 402 AUSTRALIA: VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 403 AUSTRALIA: ICU VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 404 AUSTRALIA: INHALERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 405 AUSTRALIA: HUMIDIFIERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 406 AUSTRALIA: NEBULIZERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 407 AUSTRALIA: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 408 AUSTRALIA: PULSE OXIMETERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 409 AUSTRALIA: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 410 AUSTRALIA: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 411 AUSTRALIA: MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 412 AUSTRALIA: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2021–2028 (USD MILLION)
TABLE 413 AUSTRALIA: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)
9.4.6 SOUTH KOREA
9.4.6.1 Expanding geriatric population to fuel market
TABLE 414 SOUTH KOREA: KEY MACROINDICATORS
TABLE 415 SOUTH KOREA: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 416 SOUTH KOREA: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 417 SOUTH KOREA: PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 418 SOUTH KOREA: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 419 SOUTH KOREA: VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 420 SOUTH KOREA: ICU VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 421 SOUTH KOREA: INHALERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 422 SOUTH KOREA: HUMIDIFIERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 423 SOUTH KOREA: NEBULIZERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 424 SOUTH KOREA: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 425 SOUTH KOREA: PULSE OXIMETERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 426 SOUTH KOREA: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 427 SOUTH KOREA: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 428 SOUTH KOREA: MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 429 SOUTH KOREA: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2021–2028 (USD MILLION)
TABLE 430 SOUTH KOREA: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)
9.4.7 REST OF ASIA PACIFIC
TABLE 431 REST OF ASIA PACIFIC: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 432 REST OF ASIA PACIFIC: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 433 REST OF ASIA PACIFIC: PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 434 REST OF ASIA PACIFIC: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 435 REST OF ASIA PACIFIC: VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 436 REST OF ASIA PACIFIC: ICU VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 437 REST OF ASIA PACIFIC: INHALERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 438 REST OF ASIA PACIFIC: HUMIDIFIERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 439 REST OF ASIA PACIFIC: NEBULIZERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 440 REST OF ASIA PACIFIC: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 441 REST OF ASIA PACIFIC: PULSE OXIMETERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 442 REST OF ASIA PACIFIC: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 443 REST OF ASIA PACIFIC: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 444 REST OF ASIA PACIFIC: MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 445 REST OF ASIA PACIFIC: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2021–2028 (USD MILLION)
TABLE 446 REST OF ASIA PACIFIC: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)
9.5 LATIN AMERICA
TABLE 447 LATIN AMERICA: RESPIRATORY CARE DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 448 LATIN AMERICA: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 449 LATIN AMERICA: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 450 LATIN AMERICA: PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 451 LATIN AMERICA: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 452 LATIN AMERICA: VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 453 LATIN AMERICA: ICU VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 454 LATIN AMERICA: INHALERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 455 LATIN AMERICA: HUMIDIFIERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 456 LATIN AMERICA: NEBULIZERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 457 LATIN AMERICA: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 458 LATIN AMERICA: PULSE OXIMETERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 459 LATIN AMERICA: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 460 LATIN AMERICA: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 461 LATIN AMERICA: MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 462 LATIN AMERICA: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2021–2028 (USD MILLION)
TABLE 463 LATIN AMERICA: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)
9.5.1 LATIN AMERICA: RECESSION IMPACT
9.5.2 BRAZIL
9.5.2.1 Government initiatives to improve healthcare sector to drive market
TABLE 464 BRAZIL: KEY MACROINDICATORS
TABLE 465 BRAZIL: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 466 BRAZIL: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 467 BRAZIL: PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 468 BRAZIL: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 469 BRAZIL: VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 470 BRAZIL: ICU VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 471 BRAZIL: INHALERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 472 BRAZIL: HUMIDIFIERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 473 BRAZIL: NEBULIZERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 474 BRAZIL: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 475 BRAZIL: PULSE OXIMETERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 476 BRAZIL: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 477 BRAZIL: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 478 BRAZIL: MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 479 BRAZIL: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2021–2028 (USD MILLION)
TABLE 480 BRAZIL: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)
9.5.3 MEXICO
9.5.3.1 Rising obesity rate to increase incidence of respiratory diseases
TABLE 481 MEXICO: KEY MACROINDICATORS
TABLE 482 MEXICO: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 483 MEXICO: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 484 MEXICO: PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 485 MEXICO: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 486 MEXICO: VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 487 MEXICO: ICU VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 488 MEXICO: INHALERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 489 MEXICO: HUMIDIFIERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 490 MEXICO: NEBULIZERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 491 MEXICO: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 492 MEXICO: PULSE OXIMETERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 493 MEXICO: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 494 MEXICO: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 495 MEXICO: MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 496 MEXICO: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2021–2028 (USD MILLION)
TABLE 497 MEXICO: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)
9.5.4 REST OF LATIN AMERICA
TABLE 498 REST OF LATIN AMERICA: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 499 REST OF LATIN AMERICA: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 500 REST OF LATIN AMERICA: PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 501 REST OF LATIN AMERICA: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 502 REST OF LATIN AMERICA: VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 503 REST OF LATIN AMERICA: ICU VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 504 REST OF LATIN AMERICA: INHALERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 505 REST OF LATIN AMERICA: HUMIDIFIERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 506 REST OF LATIN AMERICA: NEBULIZERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 507 REST OF LATIN AMERICA: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 508 REST OF LATIN AMERICA: PULSE OXIMETERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 509 REST OF LATIN AMERICA: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 510 REST OF LATIN AMERICA: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 511 REST OF LATIN AMERICA: MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 512 REST OF LATIN AMERICA: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2021–2028 (USD MILLION)
TABLE 513 REST OF LATIN AMERICA: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)
9.6 MIDDLE EAST & AFRICA
9.6.1 PRESENCE OF UNSATURATED MARKETS TO OFFER LUCRATIVE GROWTH OPPORTUNITIES TO PLAYERS
TABLE 514 MIDDLE EAST & AFRICA: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 515 MIDDLE EAST & AFRICA: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 516 MIDDLE EAST & AFRICA: PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 517 MIDDLE EAST & AFRICA: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 518 MIDDLE EAST & AFRICA: VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 519 MIDDLE EAST & AFRICA: ICU VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 520 MIDDLE EAST & AFRICA: INHALERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 521 MIDDLE EAST & AFRICA: HUMIDIFIERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 522 MIDDLE EAST & AFRICA: NEBULIZERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 523 MIDDLE EAST & AFRICA: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 524 MIDDLE EAST & AFRICA: PULSE OXIMETERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 525 MIDDLE EAST & AFRICA: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 526 MIDDLE EAST & AFRICA: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 527 MIDDLE EAST & AFRICA: MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 528 MIDDLE EAST & AFRICA: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2021–2028 (USD MILLION)
TABLE 529 MIDDLE EAST & AFRICA: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)
9.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT
10 COMPETITIVE LANDSCAPE
10.1 INTRODUCTION
10.2 RIGHT TO WIN/KEY STRATEGIES
10.3 STRATEGIES ADOPTED BY KEY PLAYERS
10.4 REVENUE ANALYSIS FOR TOP FIVE MARKET PLAYERS
FIGURE 39 REVENUE ANALYSIS OF TOP FIVE PLAYERS IN RESPIRATORY CARE DEVICES MARKET
10.5 MARKET SHARE ANALYSIS
FIGURE 40 RESPIRATORY CARE DEVICES MARKET SHARE, BY KEY PLAYER (2022)
FIGURE 41 SHARE OF LEADING COMPANIES IN GLOBAL THERAPEUTIC RESPIRATORY CARE DEVICES MARKET (2022)
FIGURE 42 SHARE OF LEADING COMPANIES IN GLOBAL MONITORING DEVICES MARKET (2022)
FIGURE 43 SHARE OF LEADING COMPANIES IN GLOBAL DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET (2022)
10.6 COMPANY EVALUATION MATRIX
10.6.1 STARS
10.6.2 EMERGING LEADERS
10.6.3 PERVASIVE PLAYERS
10.6.4 PARTICIPANTS
FIGURE 44 RESPIRATORY CARE DEVICES MARKET: COMPETITIVE LEADERSHIP MATRIX, 2022
10.7 COMPANY EVALUATION MATRIX FOR SMES/START-UPS (2022)
10.7.1 PROGRESSIVE COMPANIES
10.7.2 DYNAMIC COMPANIES
10.7.3 STARTING BLOCKS
10.7.4 RESPONSIVE COMPANIES
FIGURE 45 RESPIRATORY CARE DEVICES MARKET: COMPANY EVALUATION MATRIX FOR SMES/START-UPS, 2022
10.8 COMPETITIVE BENCHMARKING
TABLE 530 RESPIRATORY CARE DEVICES MARKET: KEY STARTUPS/SMES
10.8.1 COMPANY FOOTPRINT
TABLE 531 FOOTPRINT OF COMPANIES, BY OFFERING (25 COMPANIES)
TABLE 532 FOOTPRINT OF COMPANIES, BY DISEASE INDICATION (25 COMPANIES)
TABLE 533 FOOTPRINT OF COMPANIES, BY END USER (25 COMPANIES)
FIGURE 46 OVERALL FOOTPRINT OF COMPANIES (25 COMPANIES)
10.8.2 COMPETITIVE SCENARIOS AND TRENDS
10.8.3 PRODUCT LAUNCHES
TABLE 534 RESPIRATORY CARE DEVICES MARKET: PRODUCT LAUNCHES (2019–2023)
10.8.4 DEALS
TABLE 535 RESPIRATORY CARE DEVICES MARKET: DEALS (2019–2023)
11 COMPANY PROFILES
11.1 KEY PLAYERS
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
11.1.1 KONINKLIJKE PHILIPS N.V.
TABLE 536 KONINKLIJKE PHILIPS N.V.: BUSINESS OVERVIEW
FIGURE 47 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2022)
11.1.2 MEDTRONIC
TABLE 537 MEDTRONIC: BUSINESS OVERVIEW
FIGURE 48 MEDTRONIC: COMPANY SNAPSHOT (2022)
11.1.3 RESMED
TABLE 538 RESMED: BUSINESS OVERVIEW
FIGURE 49 RESMED: COMPANY SNAPSHOT (2022)
11.1.4 MASIMO
TABLE 539 MASIMO: BUSINESS OVERVIEW
FIGURE 50 MASIMO: COMPANY SNAPSHOT (2022)
11.1.5 FISHER & PAYKEL HEALTHCARE LIMITED
TABLE 540 FISHER & PAYKEL HEALTHCARE LIMITED: BUSINESS OVERVIEW
FIGURE 51 FISHER & PAYKEL HEALTHCARE LIMITED: COMPANY SNAPSHOT (2022)
11.1.6 DRÄGERWERK AG & CO. KGAA
TABLE 541 DRÄGERWERK AG & CO. KGAA: BUSINESS OVERVIEW
FIGURE 52 DRÄGERWERK AG & CO. KGAA: COMPANY SNAPSHOT (2022)
11.1.7 GETINGE
TABLE 542 GETINGE: BUSINESS OVERVIEW
FIGURE 53 GETINGE: COMPANY SNAPSHOT (2022)
11.1.8 NIHON KOHDEN CORPORATION
TABLE 543 NIHON KOHDEN CORPORATION: BUSINESS OVERVIEW
FIGURE 54 NIHON KOHDEN CORPORATION: COMPANY SNAPSHOT (2022)
11.1.9 GE HEALTHCARE
TABLE 544 GE HEALTHCARE: BUSINESS OVERVIEW
FIGURE 55 GE HEALTHCARE: COMPANY SNAPSHOT (2022)
11.1.10 VYAIRE MEDICAL, INC.
TABLE 545 VYAIRE MEDICAL, INC.: BUSINESS OVERVIEW
11.1.11 BAXTER INTERNATIONAL, INC.
TABLE 546 BAXTER INTERNATIONAL, INC.: BUSINESS OVERVIEW
FIGURE 56 BAXTER INTERNATIONAL, INC.: COMPANY SNAPSHOT (2022)
11.1.12 ADAPTHEALTH, LLC
TABLE 547 ADAPTHEALTH, LLC: BUSINESS OVERVIEW
FIGURE 57 ADAPTHEALTH, LLC: COMPANY SNAPSHOT (2022)
11.1.13 ROTECH HEALTHCARE, INC.
TABLE 548 ROTECH HEALTHCARE INC.: BUSINESS OVERVIEW
11.1.14 TELEFLEX INCORPORATED
TABLE 549 TELEFLEX INCORPORATED: BUSINESS OVERVIEW
FIGURE 58 TELEFLEX INCORPORATED: COMPANY SNAPSHOT (2022)
11.1.15 AIR LIQUIDE
TABLE 550 AIR LIQUIDE: BUSINESS OVERVIEW
FIGURE 59 AIR LIQUIDE: COMPANY SNAPSHOT (2022)
11.2 OTHER PLAYERS
11.2.1 INVACARE CORPORATION
TABLE 551 INVACARE CORPORATION: BUSINESS OVERVIEW
FIGURE 60 INVACARE CORPORATION: COMPANY SNAPSHOT (2022)
11.2.2 ICU MEDICAL
TABLE 552 ICU MEDICAL: BUSINESS OVERVIEW
FIGURE 61 ICU MEDICAL: COMPANY SNAPSHOT (2022)
11.2.3 HAMILTON MEDICAL AG
TABLE 553 HAMILTON MEDICAL AG: BUSINESS OVERVIEW
11.2.4 APEX MEDICAL CORP
TABLE 554 APEX MEDICAL CORP: BUSINESS OVERVIEW
11.2.5 MEDLINE INDUSTRIES, LP
TABLE 555 MEDLINE INDUSTRIES, LP: BUSINESS OVERVIEW
11.2.6 HUM SOCIETY FOR HOMECARE AND MEDICAL TECHNOLOGY MBH
TABLE 556 HUM SOCIETY FOR HOMECARE AND MEDICAL TECHNOLOGY MBH: BUSINESS OVERVIEW
11.2.7 NONIN
11.2.8 ALLIED MEDICAL LLC
11.2.9 DRIVE DEVILBISS HEALTHCARE
11.2.10 OMRON HEALTHCARE, INC.
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
12 APPENDIX
12.1 DISCUSSION GUIDE
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.3 CUSTOMIZATION OPTIONS
12.4 RELATED REPORTS
12.5 AUTHOR DETAILS
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS AND EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
FIGURE 1 RESPIRATORY CARE DEVICES MARKET SEGMENTATION
FIGURE 2 RESPIRATORY CARE DEVICES MARKET, BY REGION
1.3.2 YEARS CONSIDERED
1.4 CURRENCY CONSIDERED
TABLE 1 ANNUAL AVERAGE EXCHANGE RATE FOR CURRENCY CONVERSION, 2018–2022
1.5 STAKEHOLDERS
1.6 LIMITATIONS
1.7 SUMMARY OF CHANGES
1.8 RECESSION IMPACT
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
FIGURE 3 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
FIGURE 4 PRIMARY SOURCES
2.1.2.1 Key data from primary sources
2.1.2.2 Key industry insights
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 7 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION
2.2 MARKET SIZE ESTIMATION
FIGURE 8 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
FIGURE 9 REVENUE SHARE ANALYSIS ILLUSTRATION: KONINKLIJKE PHILIPS N.V.
FIGURE 10 SUPPLY-SIDE MARKET ESTIMATION: RESPIRATORY CARE DEVICES MARKET (2022)
FIGURE 11 DEMAND-SIDE MARKET ESTIMATION: VENTILATORS MARKET (2022)
FIGURE 12 TOTAL MARKET SIZE ESTIMATION: RESPIRATORY CARE DEVICES MARKET
FIGURE 13 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2023–2028)
FIGURE 14 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
FIGURE 15 TOP-DOWN APPROACH
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 16 MARKET DATA TRIANGULATION METHODOLOGY
2.4 STUDY ASSUMPTIONS
2.4.1 MARKET SHARE ASSUMPTIONS
2.4.2 RESEARCH ASSUMPTIONS
2.5 RISK ASSESSMENT
TABLE 2 RESPIRATORY CARE DEVICES MARKET: RISK ASSESSMENT ANALYSIS
2.6 RESEARCH LIMITATIONS
2.7 RECESSION IMPACT ANALYSIS
3 EXECUTIVE SUMMARY
FIGURE 17 RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION)
FIGURE 18 RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2023 VS. 2028 (USD MILLION)
FIGURE 19 RESPIRATORY CARE DEVICES MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
FIGURE 20 RESPIRATORY CARE DEVICES MARKET: GEOGRAPHICAL SNAPSHOT
4 PREMIUM INSIGHTS
4.1 RESPIRATORY CARE DEVICES MARKET OVERVIEW
FIGURE 21 HIGH TOBACCO CONSUMPTION TO BOOST MARKET GROWTH THROUGHOUT FORECAST PERIOD
4.2 NORTH AMERICA: RESPIRATORY CARE DEVICES MARKET, BY TYPE (2022)
FIGURE 22 THERAPEUTIC RESPIRATORY CARE DEVICES ACCOUNTED FOR LARGEST MARKET SHARE IN 2022
4.3 RESPIRATORY CARE DEVICES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 23 INDIA TO DISPLAY HIGHEST CAGR DURING FORECAST PERIOD
4.4 RESPIRATORY CARE DEVICES MARKET: REGIONAL MIX
FIGURE 24 NORTH AMERICA TO CONTINUE TO DOMINATE MARKET THROUGHOUT FORECAST PERIOD
4.5 RESPIRATORY CARE DEVICES MARKET: DEVELOPED VS. EMERGING ECONOMIES
FIGURE 25 EMERGING ECONOMIES TO REGISTER HIGHER CAGRS DURING FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 26 RESPIRATORY CARE DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Rising prevalence of respiratory diseases
5.2.1.1.1 Rapid growth in global geriatric population
FIGURE 27 GLOBAL GERIATRIC POPULATION, BY REGION
5.2.1.1.2 Urbanization and growing pollution levels
FIGURE 28 ANNUAL DATA OF DEATHS CAUSED BY HOUSEHOLD AND AMBIENT AIR POLLUTION, BY DISEASE
5.2.1.1.3 Growing tobacco consumption
TABLE 3 REGION-WISE DATA ON LIFESTYLE DISEASES
5.2.1.1.4 Increased adoption of sedentary lifestyles
5.2.1.2 Surging incidence rate of preterm births
TABLE 4 TOP 10 COUNTRIES WITH HIGHEST NUMBER OF PRETERM BIRTHS
TABLE 5 TOP 10 COUNTRIES WITH HIGHEST RATES OF PRETERM BIRTH PER 100 LIVE BIRTHS
5.2.1.3 Growing outbreaks of infectious diseases affecting respiratory systems
5.2.1.4 Rising population with sleep disorders
5.2.1.5 Improved patient outcomes using respiratory care devices
5.2.1.6 Surging R&D investments for technological advancement of medical devices
TABLE 6 PRODUCT LAUNCHES
5.2.2 RESTRAINTS
5.2.2.1 Unfavorable reimbursement scenario for respiratory care diagnostics
5.2.2.2 Availability of low-cost products from local manufacturers
5.2.2.3 High cost of CPAP machines
5.2.3 OPPORTUNITIES
5.2.3.1 Growing demand for home care therapeutic devices
5.2.3.2 Market growth opportunities in Asia Pacific and Latin America
5.2.3.3 Increasing preference for self-testing
5.2.3.4 Growing awareness about ill effects of untreated sleep apnea
TABLE 7 INITIATIVES TO PROMOTE AWARENESS ABOUT UNTREATED SLEEP APNEA
5.2.4 CHALLENGES
5.2.4.1 Low awareness and lack of diagnosis of respiratory diseases
5.2.4.2 Harmful effects of certain respiratory care devices on neonates
5.2.4.3 Lack of patient compliance with CPAP therapy
5.3 INDUSTRY TRENDS
5.3.1 RISING DEMAND FOR ENHANCED COMPACT AND PORTABLE DEVICES
5.3.2 KEY FOCUS OF MARKET PLAYERS ON GEOGRAPHICAL EXPANSION
5.3.3 GROWING DEMAND FOR MULTIMODAL VENTILATION
5.3.4 RISING ADOPTION OF NON-INVASIVE VENTILATION
FIGURE 29 IMPACT OF INNOVATIVE SOLUTIONS
FIGURE 30 INTRODUCTION OF INNOVATIVE SOLUTIONS FOR SLEEP APNEA TREATMENT
5.4 REGULATORY ANALYSIS
5.4.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 8 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 9 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 10 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.4.2 NORTH AMERICA
5.4.2.1 US
TABLE 11 US: CLASSIFICATION OF MEDICAL EQUIPMENT
TABLE 12 US: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
5.4.2.2 Canada
TABLE 13 CANADA: LEVEL OF RISK, TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
5.4.3 EUROPE
TABLE 14 EUROPE: LEVEL OF RISK, TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
5.4.4 ASIA PACIFIC
5.4.4.1 Japan
TABLE 15 JAPAN: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
5.4.4.2 China
TABLE 16 CHINA: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
5.4.4.3 India
5.5 ECOSYSTEM ANALYSIS
FIGURE 31 RESPIRATORY CARE DEVICES MARKET: ECOSYSTEM ANALYSIS
5.6 VALUE CHAIN ANALYSIS
FIGURE 32 RESPIRATORY CARE DEVICES MARKET: VALUE CHAIN ANALYSIS
5.7 IMPACT OF COVID-19 ON RESPIRATORY CARE DEVICES MARKET
5.8 TECHNOLOGY ANALYSIS
5.8.1 E-NOSE TECHNOLOGY
5.8.2 MEMS TECHNOLOGY
5.8.3 ELECTROCHEMICAL TECHNOLOGY
5.8.4 WIRELESS GAS SENSOR TECHNOLOGY
5.9 PATENT ANALYSIS
5.9.1 PATENT PUBLICATION TRENDS FOR RESPIRATORY CARE DEVICES
FIGURE 33 PATENT PUBLICATION TRENDS (2015–2023)
5.9.2 TOP APPLICANTS FOR RESPIRATORY CARE DEVICE PATENTS, BY GEOGRAPHY (2015–2023)
TABLE 17 TOP APPLICANTS FOR RESPIRATORY CARE DEVICE PATENTS, BY GEOGRAPHY
5.9.3 RESPIRATORY CARE DEVICES MARKET: TOP APPLICANTS
FIGURE 34 TOP APPLICANTS FOR RESPIRATORY CARE DEVICES PATENTS (2015–2023)
5.10 TRADE ANALYSIS
TABLE 18 TOP EXPORTERS OF MEDICAL VENTILATORS, CPAP, BIPAP, AND OXYGEN CONCENTRATORS, 2021
5.11 CASE STUDY ANALYSIS
TABLE 19 REPLACEMENT PATTERN OF VENTILATORS: DEVELOPED ECONOMIES VS. EMERGING ECONOMIES
TABLE 20 VOLUME DATA OF VENTILATORS, ICU VENTILATORS, PORTABLE VENTILATORS, PAP DEVICES, CPAP DEVICES, BIPAP DEVICES, AND SPIROMETERS
5.12 PORTER’S FIVE FORCES ANALYSIS
TABLE 21 PORTER’S FIVE FORCES ANALYSIS
5.12.1 THREAT OF NEW ENTRANTS
5.12.2 THREAT OF SUBSTITUTES
5.12.3 BARGAINING POWER OF SUPPLIERS
5.12.4 BARGAINING POWER OF BUYERS
5.12.5 INTENSITY OF COMPETITIVE RIVALRY
5.13 KEY CONFERENCES AND EVENTS, 2023–2024
5.13.1 RESPIRATORY CARE DEVICES MARKET: LIST OF KEY CONFERENCES AND EVENTS
5.14 KEY STAKEHOLDERS AND BUYING CRITERIA
5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS
TABLE 22 STAKEHOLDERS IN BUYING PROCESS FOR RESPIRATORY CARE DEVICES
TABLE 23 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR RESPIRATORY CARE DEVICES
5.14.2 BUYING CRITERIA
FIGURE 35 KEY BUYING CRITERIA FOR RESPIRATORY DEVICES
TABLE 24 KEY BUYING CRITERIA FOR RESPIRATORY CARE DEVICES
5.15 PRICING ANALYSIS
TABLE 25 AVERAGE SELLING PRICE OF RESPIRATORY CARE DEVICES
5.16 UNMET NEEDS PERTAINING TO RESPIRATORY CARE DEVICES
TABLE 26 RESPIRATORY CARE DEVICES MARKET: UNMET NEEDS
5.16.1 END USER EXPECTATIONS
TABLE 27 RESPIRATORY CARE DEVICES MARKET: END USER EXPECTATIONS
5.17 APPLICATION OF ARTIFICIAL INTELLIGENCE IN RESPIRATORY CARE DEVICES
TABLE 28 RESPIRATORY CARE DEVICES MARKET: APPLICATION OF ARTIFICIAL INTELLIGENCE
5.17.1 FUTURE OF HEALTHCARE—BIG DATA AND ARTIFICIAL INTELLIGENCE
5.18 REIMBURSEMENT SCENARIO
TABLE 29 RESPIRATORY CARE DEVICES MARKET: REIMBURSEMENT SCENARIO
6 RESPIRATORY CARE DEVICES MARKET, BY PRODUCT
6.1 INTRODUCTION
TABLE 30 RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 31 RESPIRATORY CARE DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.2 THERAPEUTIC RESPIRATORY CARE DEVICES
TABLE 32 THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 33 THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.2.1 PAP DEVICES
TABLE 34 PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 35 PAP DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 36 PAP DEVICES MARKET, BY REGION, 2021–2028 (THOUSAND UNITS)
6.2.1.1 CPAP devices
6.2.1.1.1 Growing popularity of nasal CPAP therapies to drive demand
TABLE 37 MAJOR PLAYERS OFFERING CPAP DEVICES IN MARKET
TABLE 38 CPAP DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 39 CPAP DEVICES MARKET, BY REGION, 2021–2028 (THOUSAND UNITS)
6.2.1.2 APAP devices
6.2.1.2.1 Rising awareness among sleep specialists and patients regarding additional features of APAP devices to boost market
TABLE 40 MAJOR PLAYERS OFFERING APAP DEVICES IN MARKET
TABLE 41 APAP DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 42 APAP DEVICES MARKET, BY REGION, 2021–2028 (THOUSAND UNITS)
6.2.1.3 BiPAP devices
6.2.1.3.1 Increasing number of hospitals to strengthen market
TABLE 43 MAJOR PLAYERS OFFERING BIPAP DEVICES IN MARKET
TABLE 44 BIPAP DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 45 BIPAP DEVICES MARKET, BY REGION, 2021–2028 (THOUSAND UNITS)
6.2.2 VENTILATORS
TABLE 46 VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 47 VENTILATORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 48 VENTILATORS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS)
6.2.2.1 ICU ventilators
TABLE 49 MAJOR PLAYERS OFFERING ICU VENTILATORS IN MARKET
TABLE 50 ICU VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 51 ICU VENTILATORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 52 ICU VENTILATORS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS)
6.2.2.1.1 High-end ventilators
6.2.2.1.1.1 Improving healthcare infrastructure and rising healthcare expenditure to drive market
TABLE 53 HIGH-END VENTILATORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 54 HIGH-END VENTILATORS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS)
6.2.2.1.2 Mid-end ventilators
6.2.2.1.2.1 Better affordability and accessibility of mid-end ventilators than high-end models to support market growth
TABLE 55 MID-END VENTILATORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 56 MID-END VENTILATORS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS)
6.2.2.1.3 Basic ventilators
6.2.2.1.3.1 Expanding access to critical healthcare facilities in developing countries to spur demand
TABLE 57 BASIC VENTILATORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 58 BASIC VENTILATORS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS)
6.2.2.2 Portable/Transportable ventilators
6.2.2.2.1 Increasing demand for home care to boost segmental growth
TABLE 59 MAJOR PLAYERS OFFERING PORTABLE/TRANSPORTABLE VENTILATORS IN MARKET
TABLE 60 PORTABLE/TRANSPORTABLE VENTILATORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 61 PORTABLE/TRANSPORTABLE VENTILATORS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS)
6.2.3 NEBULIZERS
TABLE 62 MAJOR PLAYERS OFFERING NEBULIZERS IN MARKET
TABLE 63 NEBULIZERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 64 NEBULIZERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 65 NEBULIZERS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS)
6.2.3.1 Jet nebulizers
6.2.3.1.1 Increasing prevalence of respiratory conditions to augment market size
TABLE 66 JET NEBULIZERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 67 JET NEBULIZERS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS)
6.2.3.2 Mesh nebulizers
6.2.3.2.1 Deployment of advanced aerosolization technology to drive market
TABLE 68 MESH NEBULIZERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 69 MESH NEBULIZERS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS)
6.2.3.3 Ultrasonic nebulizers
6.2.3.3.1 Adjustable settings for particle size and treatment duration to boost market
TABLE 70 ULTRASONIC NEBULIZERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 71 ULTRASONIC NEBULIZERS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS)
6.2.4 HUMIDIFIERS
TABLE 72 HUMIDIFIERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 73 HUMIDIFIERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 74 HUMIDIFIERS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS)
6.2.4.1 Heated humidifiers
6.2.4.1.1 Ease of control and customizability to grow market
TABLE 75 MAJOR PLAYERS OFFERING HEATED HUMIDIFIERS IN MARKET
TABLE 76 HEATED HUMIDIFIERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 77 HEATED HUMIDIFIERS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS)
6.2.4.2 Passover humidifiers
6.2.4.2.1 Minimal maintenance and simple technology to spur demand
TABLE 78 MAJOR PLAYERS OFFERING PASSOVER HUMIDIFIERS IN MARKET
TABLE 79 PASSOVER HUMIDIFIERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 80 PASSOVER HUMIDIFIERS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS)
6.2.5 OXYGEN CONCENTRATORS
TABLE 81 MAJOR PLAYERS OFFERING OXYGEN CONCENTRATORS IN MARKET
TABLE 82 OXYGEN CONCENTRATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 83 OXYGEN CONCENTRATORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 84 OXYGEN CONCENTRATORS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS)
6.2.5.1 Fixed oxygen concentrators
6.2.5.1.1 Better access to healthcare services to grow demand
TABLE 85 FIXED OXYGEN CONCENTRATORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 86 FIXED OXYGEN CONCENTRATORS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS)
6.2.5.2 Portable oxygen concentrators
6.2.5.2.1 Low weight and easy setup to drive segmental growth
TABLE 87 PORTABLE OXYGEN CONCENTRATORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 88 PORTABLE OXYGEN CONCENTRATORS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS)
6.2.6 INHALERS
TABLE 89 INHALERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 90 INHALERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 91 INHALERS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS)
6.2.6.1 Metered-dose inhalers (MDIs)
6.2.6.1.1 Ongoing advancements in MDI technology to support market growth
TABLE 92 METERED-DOSE INHALERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 93 METERED-DOSE INHALERS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS)
6.2.6.2 Dry powder inhalers (DPIs)
6.2.6.2.1 Developments in particle engineering and powder formulations to boost segmental growth
TABLE 94 DRY POWDER INHALERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 95 DRY POWDER INHALERS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS)
6.2.7 REUSABLE RESUSCITATORS
6.2.7.1 Disposable and reusable nature to drive demand
TABLE 96 MAJOR PLAYERS OFFERING REUSABLE RESUSCITATORS IN MARKET
TABLE 97 REUSABLE RESUSCITATORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 98 REUSABLE RESUSCITATORS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS)
6.2.8 NITRIC OXIDE DELIVERY UNITS
6.2.8.1 Rising emphasis of companies on developing innovative and advanced nitric oxide delivery units to drive market
TABLE 99 MAJOR PLAYERS OFFERING NITRIC OXIDE DELIVERY UNITS IN MARKET
TABLE 100 NITRIC OXIDE DELIVERY UNITS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 101 NITRIC OXIDE DELIVERY UNITS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS)
6.2.9 OXYGEN HOODS
6.2.9.1 Growing prevalence of respiratory diseases in kids to drive market growth
TABLE 102 MAJOR PLAYERS OFFERING OXYGEN HOODS IN MARKET
TABLE 103 OXYGEN HOODS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 104 OXYGEN HOODS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS)
6.3 MONITORING DEVICES
TABLE 105 RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 106 RESPIRATORY CARE MONITORING DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.3.1 PULSE OXIMETERS
TABLE 107 MAJOR PLAYERS OFFERING PULSE OXIMETERS IN MARKET
TABLE 108 PULSE OXIMETERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 109 PULSE OXIMETERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 110 PULSE OXIMETERS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS)
6.3.1.1 Pulse oximeter sensors
6.3.1.1.1 Development of advanced sensors with embedded chips to boost segmental growth
TABLE 111 PULSE OXIMETER SENSORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 112 PULSE OXIMETER SENSORS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS)
6.3.1.2 Pulse oximeter equipment
6.3.1.2.1 Growing prevalence of chronic respiratory conditions to boost demand
TABLE 113 MAJOR PLAYERS OFFERING PULSE OXIMETER EQUIPMENT IN MARKET
TABLE 114 PULSE OXIMETER EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 115 PULSE OXIMETER EQUIPMENT MARKET, BY REGION, 2021–2028 (THOUSAND UNITS)
6.3.2 CAPNOGRAPHS
6.3.2.1 Ongoing R&D on capnographs to offer lucrative growth opportunities
TABLE 116 MAJOR PLAYERS OFFERING CAPNOGRAPHS IN MARKET
TABLE 117 CAPNOGRAPHS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 118 CAPNOGRAPHS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS)
6.3.3 GAS ANALYZERS
6.3.3.1 Increasing demand for point-of-care testing to drive demand
TABLE 119 MAJOR PLAYERS OFFERING GAS ANALYZERS IN MARKET
TABLE 120 GAS ANALYZERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 121 GAS ANALYZERS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS)
6.4 DIAGNOSTIC RESPIRATORY CARE DEVICES
TABLE 122 DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 123 DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.4.1 SPIROMETERS
6.4.1.1 Rising technological advancements in spirometers to support market growth
TABLE 124 MAJOR PLAYERS OFFERING SPIROMETERS IN MARKET
TABLE 125 SPIROMETERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 126 SPIROMETERS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS)
6.4.2 POLYSOMNOGRAPHY DEVICES (PSG DEVICES)
6.4.2.1 Rising incidence of obstructive sleep apnea to drive demand
TABLE 127 MAJOR PLAYERS OFFERING POLYSOMNOGRAPHY DEVICES IN MARKET
TABLE 128 POLYSOMNOGRAPHY DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 129 POLYSOMNOGRAPHY DEVICES MARKET, BY REGION, 2021–2028 (THOUSAND UNITS)
6.4.3 PEAK FLOW METERS
6.4.3.1 Low-cost and uncomplicated nature to drive segmental growth
TABLE 130 MAJOR PLAYERS OFFERING PEAK FLOW METERS IN MARKET
TABLE 131 PEAK FLOW METERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 132 PEAK FLOW METERS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS)
6.4.4 OTHER DIAGNOSTIC DEVICES
TABLE 133 OTHER DIAGNOSTIC DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.5 CONSUMABLES & ACCESSORIES
TABLE 134 RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 135 RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.5.1 MASKS
TABLE 136 MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 137 MASKS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.5.1.1 Reusable masks
6.5.1.1.1 Growing concerns related to air pollution to grow demand
TABLE 138 REUSABLE MASKS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.5.1.2 Disposable masks
6.5.1.2.1 Stringent government mandates on wearing masks to spur demand
TABLE 139 DISPOSABLE MASKS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.5.2 DISPOSABLE RESUSCITATORS
6.5.2.1 Growing focus on reducing cross-contamination cases in patients to foster segmental growth
TABLE 140 DISPOSABLE RESUSCITATORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.5.3 TRACHEOSTOMY TUBES
6.5.3.1 Introduction of new and advanced products with ergonomic designs to drive market growth
TABLE 141 TRACHEOSTOMY TUBES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.5.4 BREATHING CIRCUITS
6.5.4.1 Healthcare professionals’ efforts to improve infection control practices to grow demand
TABLE 142 BREATHING CIRCUITS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.5.5 NASAL CANNULAE
6.5.5.1 Increasing focus on minimally invasive surgery techniques to fuel demand
TABLE 143 NASAL CANNULAE MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.5.6 OTHER CONSUMABLES & ACCESSORIES
TABLE 144 OTHER CONSUMABLES & ACCESSORIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
7 RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION
7.1 INTRODUCTION
TABLE 145 RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2021–2028 (USD MILLION)
7.2 CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
7.2.1 RISING INDOOR AND OUTDOOR AIR POLLUTION LEVELS TO DRIVE MARKET
TABLE 146 RESPIRATORY CARE DEVICES MARKET FOR COPD, BY COUNTRY, 2021–2028 (USD MILLION)
7.3 SLEEP APNEA
7.3.1 GROWING INCIDENCE OF OBESITY AND CARDIOVASCULAR DISEASES TO FAVOR MARKET GROWTH
TABLE 147 COUNTRY-WISE DATA ON SLEEP APNEA PATIENTS
TABLE 148 RESPIRATORY CARE DEVICES MARKET FOR SLEEP APNEA, BY COUNTRY, 2021–2028 (USD MILLION)
7.4 ASTHMA
7.4.1 INCREASING INCIDENCE OF COPD TO DRIVE MARKET
TABLE 149 RESPIRATORY CARE DEVICES MARKET FOR ASTHMA, BY COUNTRY, 2021–2028 (USD MILLION)
7.5 INFECTIOUS DISEASES
7.5.1 GROWING NUMBER OF TB PATIENTS TO BOOST MARKET GROWTH
TABLE 150 INCIDENCE OF TB (RATE PER 100,000 POPULATION)
TABLE 151 RESPIRATORY CARE DEVICES MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2021–2028 (USD MILLION)
7.6 OTHER DISEASE INDICATIONS
TABLE 152 RESPIRATORY CARE DEVICES MARKET FOR OTHER DISEASE INDICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
8 RESPIRATORY CARE DEVICES MARKET, BY END USER
8.1 INTRODUCTION
TABLE 153 RESPIRATORY CARE DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)
8.2 HOSPITALS
8.2.1 GROWING NUMBER OF HOSPITALS IN EMERGING ECONOMIES TO DRIVE MARKET
TABLE 154 RESPIRATORY CARE DEVICES MARKET FOR HOSPITALS, BY COUNTRY, 2021–2028 (USD MILLION)
8.3 HOME CARE SETTINGS
8.3.1 INCREASING ACCEPTANCE OF HOME CARE DEVICES BY PATIENTS TO BOOST GROWTH
TABLE 155 RESPIRATORY CARE DEVICES MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2021–2028 (USD MILLION)
8.4 AMBULATORY CARE CENTERS (ACCS)
8.4.1 IMPROVED PATIENT EXPERIENCE IN AMBULATORY CARE CENTERS TO DRIVE MARKET
TABLE 156 RESPIRATORY CARE DEVICES MARKET FOR AMBULATORY CARE CENTERS, BY COUNTRY, 2021–2028 (USD MILLION)
8.5 OTHER END USERS
TABLE 157 RESPIRATORY CARE DEVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION)
9 RESPIRATORY CARE DEVICES MARKET, BY REGION
9.1 INTRODUCTION
FIGURE 36 RESPIRATORY CARE DEVICES MARKET: REGIONAL GROWTH OPPORTUNITIES
TABLE 158 RESPIRATORY CARE DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION)
9.2 NORTH AMERICA
FIGURE 37 NORTH AMERICA: RESPIRATORY CARE DEVICES MARKET SNAPSHOT
TABLE 159 NORTH AMERICA: RESPIRATORY CARE DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 160 NORTH AMERICA: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 161 NORTH AMERICA: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 162 NORTH AMERICA: PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 163 NORTH AMERICA: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 164 NORTH AMERICA: VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 165 NORTH AMERICA: ICU VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 166 NORTH AMERICA: INHALERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 167 NORTH AMERICA: HUMIDIFIERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 168 NORTH AMERICA: NEBULIZERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 169 NORTH AMERICA: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 170 NORTH AMERICA: PULSE OXIMETERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 171 NORTH AMERICA: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 172 NORTH AMERICA: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 173 NORTH AMERICA: MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 174 NORTH AMERICA: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2021–2028 (USD MILLION)
TABLE 175 NORTH AMERICA: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)
9.2.1 NORTH AMERICA: RECESSION IMPACT
9.2.2 US
9.2.2.1 Rapid growth in geriatric population to boost market
TABLE 176 US: KEY MACROINDICATORS
TABLE 177 US: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 178 US: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 179 US: PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 180 US: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 181 US: VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 182 US: ICU VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 183 US: INHALERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 184 US: HUMIDIFIERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 185 US: NEBULIZERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 186 US: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 187 US: PULSE OXIMETERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 188 US: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 189 US: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 190 US: MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 191 US: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2021–2028 (USD MILLION)
TABLE 192 US: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)
9.2.3 CANADA
9.2.3.1 Large pool of undiagnosed patients to drive market
TABLE 193 CANADA: COPD AND ASTHMA STATISTICS (2019 VS. 2020)
TABLE 194 CANADA: KEY MACROINDICATORS
TABLE 195 CANADA: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 196 CANADA: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 197 CANADA: PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 198 CANADA: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 199 CANADA: VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 200 CANADA: ICU VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 201 CANADA: INHALERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 202 CANADA: HUMIDIFIERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 203 CANADA: NEBULIZERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 204 CANADA: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 205 CANADA: PULSE OXIMETERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 206 CANADA: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 207 CANADA: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 208 CANADA: MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 209 CANADA: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2021–2028 (USD MILLION)
TABLE 210 CANADA: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)
9.3 EUROPE
TABLE 211 EUROPE: RESPIRATORY CARE DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 212 EUROPE: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 213 EUROPE: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 214 EUROPE: PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 215 EUROPE: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 216 EUROPE: VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 217 EUROPE: ICU VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 218 EUROPE: INHALERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 219 EUROPE: HUMIDIFIERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 220 EUROPE: NEBULIZER MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 221 EUROPE: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 222 EUROPE: PULSE OXIMETERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 223 EUROPE: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 224 EUROPE: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 225 EUROPE: MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 226 EUROPE: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2021–2028 (USD MILLION)
TABLE 227 EUROPE: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)
9.3.1 EUROPE: RECESSION IMPACT
9.3.2 GERMANY
9.3.2.1 Increasing public healthcare expenditure to foster market growth
TABLE 228 GERMANY: KEY MACROINDICA"
TORS
TABLE 229 GERMANY: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 230 GERMANY: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 231 GERMANY: PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 232 GERMANY: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 233 GERMANY: VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 234 GERMANY: ICU VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 235 GERMANY: INHALERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 236 GERMANY: HUMIDIFIERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 237 GERMANY: NEBULIZERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 238 GERMANY: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 239 GERMANY: PULSE OXIMETERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 240 GERMANY: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 241 GERMANY: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 242 GERMANY: MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 243 GERMANY: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2021–2028 (USD MILLION)
TABLE 244 GERMANY: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)
9.3.3 FRANCE
9.3.3.1 High prevalence of COPD to surge demand
TABLE 245 FRANCE: KEY MACROINDICATORS
TABLE 246 FRANCE: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 247 FRANCE: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 248 FRANCE: PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 249 FRANCE: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 250 FRANCE: VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 251 FRANCE: ICU VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 252 FRANCE: INHALERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 253 FRANCE: HUMIDIFIERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 254 FRANCE: NEBULIZERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 255 FRANCE: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 256 FRANCE: PULSE OXIMETERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 257 FRANCE: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 258 FRANCE: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 259 FRANCE: MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 260 FRANCE: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2021–2028 (USD MILLION)
TABLE 261 FRANCE: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)
9.3.4 UK
9.3.4.1 Growing demand for minimally invasive surgeries to drive market
TABLE 262 UK: KEY MACROINDICATORS
TABLE 263 UK: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 264 UK: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 265 UK: PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 266 UK: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 267 UK: VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 268 UK: ICU VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 269 UK: INHALERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 270 UK: HUMIDIFIERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 271 UK: NEBULIZERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 272 UK: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 273 UK: PULSE OXIMETERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 274 UK: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 275 UK: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 276 UK: MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 277 UK: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2021–2028 (USD MILLION)
TABLE 278 UK: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)
9.3.5 ITALY
9.3.5.1 Growing involvement of private sector in healthcare market to drive market
TABLE 279 ITALY: KEY MACROINDICATORS
TABLE 280 ITALY: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 281 ITALY: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 282 ITALY: PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 283 ITALY: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 284 ITALY: VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 285 ITALY: ICU VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 286 ITALY: INHALERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 287 ITALY: HUMIDIFIERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 288 ITALY: NEBULIZERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 289 ITALY: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 290 ITALY: PULSE OXIMETERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 291 ITALY: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 292 ITALY: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 293 ITALY: MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 294 ITALY: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2021–2028 (USD MILLION)
TABLE 295 ITALY: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)
9.3.6 SPAIN
9.3.6.1 Need to improve healthcare infrastructure due to aging demographic to drive demand
TABLE 296 SPAIN: KEY MACROINDICATORS
TABLE 297 SPAIN: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 298 SPAIN: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 299 SPAIN: PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 300 SPAIN: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 301 SPAIN: VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 302 SPAIN: ICU VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 303 SPAIN: INHALERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 304 SPAIN: HUMIDIFIERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 305 SPAIN: NEBULIZERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 306 SPAIN: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 307 SPAIN: PULSE OXIMETERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 308 SPAIN: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 309 SPAIN: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 310 SPAIN: MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 311 SPAIN: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2021–2028 (USD MILLION)
TABLE 312 SPAIN: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)
9.3.7 REST OF EUROPE
TABLE 313 REST OF EUROPE: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 314 REST OF EUROPE: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 315 REST OF EUROPE: PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 316 REST OF EUROPE: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 317 REST OF EUROPE: VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 318 REST OF EUROPE: ICU VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 319 REST OF EUROPE: INHALERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 320 REST OF EUROPE: HUMIDIFIERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 321 REST OF EUROPE: NEBULIZERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 322 REST OF EUROPE: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 323 REST OF EUROPE: PULSE OXIMETERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 324 REST OF EUROPE: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 325 REST OF EUROPE: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 326 REST OF EUROPE: MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 327 REST OF EUROPE: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2021–2028 (USD MILLION)
TABLE 328 REST OF EUROPE: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)
9.4 ASIA PACIFIC
FIGURE 38 ASIA PACIFIC: RESPIRATORY CARE DEVICES MARKET SNAPSHOT
TABLE 329 ASIA PACIFIC: RESPIRATORY CARE DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 330 ASIA PACIFIC: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 331 ASIA PACIFIC: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 332 ASIA PACIFIC: PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 333 ASIA PACIFIC: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 334 ASIA PACIFIC: VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 335 ASIA PACIFIC: ICU VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 336 ASIA PACIFIC: INHALERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 337 ASIA PACIFIC: HUMIDIFIERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 338 ASIA PACIFIC: NEBULIZERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 339 ASIA PACIFIC: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 340 ASIA PACIFIC: PULSE OXIMETERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 341 ASIA PACIFIC: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 342 ASIA PACIFIC: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 343 ASIA PACIFIC: MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 344 ASIA PACIFIC: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2021–2028 (USD MILLION)
TABLE 345 ASIA PACIFIC: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)
9.4.1 ASIA PACIFIC: RECESSION IMPACT
9.4.2 JAPAN
9.4.2.1 Availability of universal healthcare reimbursement policy to drive market
TABLE 346 JAPAN: KEY MACROINDICATORS
TABLE 347 JAPAN: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 348 JAPAN: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 349 JAPAN: PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 350 JAPAN: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 351 JAPAN: VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 352 JAPAN: ICU VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 353 JAPAN: INHALERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 354 JAPAN: HUMIDIFIERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 355 JAPAN: NEBULIZERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 356 JAPAN: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 357 JAPAN: PULSE OXIMETERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 358 JAPAN: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 359 JAPAN: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 360 JAPAN: MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 361 JAPAN: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2021–2028 (USD MILLION)
TABLE 362 JAPAN: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)
9.4.3 CHINA
9.4.3.1 Initiatives to modernize healthcare system and reimbursement facilities to support market growth
TABLE 363 CHINA: KEY MACROINDICATORS
TABLE 364 CHINA: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 365 CHINA: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 366 CHINA: PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 367 CHINA: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 368 CHINA: VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 369 CHINA: ICU VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 370 CHINA: INHALERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 371 CHINA: HUMIDIFIERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 372 CHINA: NEBULIZERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 373 CHINA: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 374 CHINA: PULSE OXIMETERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 375 CHINA: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 376 CHINA: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 377 CHINA: MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 378 CHINA: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2021–2028 (USD MILLION)
TABLE 379 CHINA: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)
9.4.4 INDIA
9.4.4.1 Increasing focus of global players on domestic market to drive market
TABLE 380 INDIA: KEY MACROINDICATORS
TABLE 381 INDIA: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 382 INDIA: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 383 INDIA: PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 384 INDIA: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 385 INDIA: VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 386 INDIA: ICU VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 387 INDIA: INHALERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 388 INDIA: HUMIDIFIERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 389 INDIA: NEBULIZERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 390 INDIA: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 391 INDIA: PULSE OXIMETERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 392 INDIA: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 393 INDIA: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 394 INDIA: MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 395 INDIA: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2021–2028 (USD MILLION)
TABLE 396 INDIA: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)
9.4.5 AUSTRALIA
9.4.5.1 High prevalence of chronic lung diseases to drive demand
TABLE 397 AUSTRALIA: KEY MACROINDICATORS
TABLE 398 AUSTRALIA: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 399 AUSTRALIA: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 400 AUSTRALIA: PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 401 AUSTRALIA: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 402 AUSTRALIA: VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 403 AUSTRALIA: ICU VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 404 AUSTRALIA: INHALERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 405 AUSTRALIA: HUMIDIFIERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 406 AUSTRALIA: NEBULIZERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 407 AUSTRALIA: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 408 AUSTRALIA: PULSE OXIMETERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 409 AUSTRALIA: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 410 AUSTRALIA: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 411 AUSTRALIA: MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 412 AUSTRALIA: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2021–2028 (USD MILLION)
TABLE 413 AUSTRALIA: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)
9.4.6 SOUTH KOREA
9.4.6.1 Expanding geriatric population to fuel market
TABLE 414 SOUTH KOREA: KEY MACROINDICATORS
TABLE 415 SOUTH KOREA: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 416 SOUTH KOREA: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 417 SOUTH KOREA: PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 418 SOUTH KOREA: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 419 SOUTH KOREA: VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 420 SOUTH KOREA: ICU VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 421 SOUTH KOREA: INHALERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 422 SOUTH KOREA: HUMIDIFIERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 423 SOUTH KOREA: NEBULIZERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 424 SOUTH KOREA: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 425 SOUTH KOREA: PULSE OXIMETERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 426 SOUTH KOREA: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 427 SOUTH KOREA: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 428 SOUTH KOREA: MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 429 SOUTH KOREA: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2021–2028 (USD MILLION)
TABLE 430 SOUTH KOREA: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)
9.4.7 REST OF ASIA PACIFIC
TABLE 431 REST OF ASIA PACIFIC: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 432 REST OF ASIA PACIFIC: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 433 REST OF ASIA PACIFIC: PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 434 REST OF ASIA PACIFIC: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 435 REST OF ASIA PACIFIC: VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 436 REST OF ASIA PACIFIC: ICU VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 437 REST OF ASIA PACIFIC: INHALERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 438 REST OF ASIA PACIFIC: HUMIDIFIERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 439 REST OF ASIA PACIFIC: NEBULIZERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 440 REST OF ASIA PACIFIC: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 441 REST OF ASIA PACIFIC: PULSE OXIMETERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 442 REST OF ASIA PACIFIC: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 443 REST OF ASIA PACIFIC: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 444 REST OF ASIA PACIFIC: MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 445 REST OF ASIA PACIFIC: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2021–2028 (USD MILLION)
TABLE 446 REST OF ASIA PACIFIC: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)
9.5 LATIN AMERICA
TABLE 447 LATIN AMERICA: RESPIRATORY CARE DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 448 LATIN AMERICA: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 449 LATIN AMERICA: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 450 LATIN AMERICA: PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 451 LATIN AMERICA: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 452 LATIN AMERICA: VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 453 LATIN AMERICA: ICU VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 454 LATIN AMERICA: INHALERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 455 LATIN AMERICA: HUMIDIFIERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 456 LATIN AMERICA: NEBULIZERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 457 LATIN AMERICA: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 458 LATIN AMERICA: PULSE OXIMETERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 459 LATIN AMERICA: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 460 LATIN AMERICA: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 461 LATIN AMERICA: MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 462 LATIN AMERICA: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2021–2028 (USD MILLION)
TABLE 463 LATIN AMERICA: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)
9.5.1 LATIN AMERICA: RECESSION IMPACT
9.5.2 BRAZIL
9.5.2.1 Government initiatives to improve healthcare sector to drive market
TABLE 464 BRAZIL: KEY MACROINDICATORS
TABLE 465 BRAZIL: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 466 BRAZIL: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 467 BRAZIL: PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 468 BRAZIL: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 469 BRAZIL: VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 470 BRAZIL: ICU VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 471 BRAZIL: INHALERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 472 BRAZIL: HUMIDIFIERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 473 BRAZIL: NEBULIZERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 474 BRAZIL: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 475 BRAZIL: PULSE OXIMETERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 476 BRAZIL: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 477 BRAZIL: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 478 BRAZIL: MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 479 BRAZIL: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2021–2028 (USD MILLION)
TABLE 480 BRAZIL: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)
9.5.3 MEXICO
9.5.3.1 Rising obesity rate to increase incidence of respiratory diseases
TABLE 481 MEXICO: KEY MACROINDICATORS
TABLE 482 MEXICO: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 483 MEXICO: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 484 MEXICO: PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 485 MEXICO: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 486 MEXICO: VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 487 MEXICO: ICU VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 488 MEXICO: INHALERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 489 MEXICO: HUMIDIFIERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 490 MEXICO: NEBULIZERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 491 MEXICO: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 492 MEXICO: PULSE OXIMETERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 493 MEXICO: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 494 MEXICO: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 495 MEXICO: MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 496 MEXICO: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2021–2028 (USD MILLION)
TABLE 497 MEXICO: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)
9.5.4 REST OF LATIN AMERICA
TABLE 498 REST OF LATIN AMERICA: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 499 REST OF LATIN AMERICA: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 500 REST OF LATIN AMERICA: PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 501 REST OF LATIN AMERICA: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 502 REST OF LATIN AMERICA: VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 503 REST OF LATIN AMERICA: ICU VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 504 REST OF LATIN AMERICA: INHALERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 505 REST OF LATIN AMERICA: HUMIDIFIERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 506 REST OF LATIN AMERICA: NEBULIZERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 507 REST OF LATIN AMERICA: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 508 REST OF LATIN AMERICA: PULSE OXIMETERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 509 REST OF LATIN AMERICA: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 510 REST OF LATIN AMERICA: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 511 REST OF LATIN AMERICA: MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 512 REST OF LATIN AMERICA: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2021–2028 (USD MILLION)
TABLE 513 REST OF LATIN AMERICA: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)
9.6 MIDDLE EAST & AFRICA
9.6.1 PRESENCE OF UNSATURATED MARKETS TO OFFER LUCRATIVE GROWTH OPPORTUNITIES TO PLAYERS
TABLE 514 MIDDLE EAST & AFRICA: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 515 MIDDLE EAST & AFRICA: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 516 MIDDLE EAST & AFRICA: PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 517 MIDDLE EAST & AFRICA: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 518 MIDDLE EAST & AFRICA: VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 519 MIDDLE EAST & AFRICA: ICU VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 520 MIDDLE EAST & AFRICA: INHALERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 521 MIDDLE EAST & AFRICA: HUMIDIFIERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 522 MIDDLE EAST & AFRICA: NEBULIZERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 523 MIDDLE EAST & AFRICA: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 524 MIDDLE EAST & AFRICA: PULSE OXIMETERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 525 MIDDLE EAST & AFRICA: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 526 MIDDLE EAST & AFRICA: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 527 MIDDLE EAST & AFRICA: MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 528 MIDDLE EAST & AFRICA: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2021–2028 (USD MILLION)
TABLE 529 MIDDLE EAST & AFRICA: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)
9.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT
10 COMPETITIVE LANDSCAPE
10.1 INTRODUCTION
10.2 RIGHT TO WIN/KEY STRATEGIES
10.3 STRATEGIES ADOPTED BY KEY PLAYERS
10.4 REVENUE ANALYSIS FOR TOP FIVE MARKET PLAYERS
FIGURE 39 REVENUE ANALYSIS OF TOP FIVE PLAYERS IN RESPIRATORY CARE DEVICES MARKET
10.5 MARKET SHARE ANALYSIS
FIGURE 40 RESPIRATORY CARE DEVICES MARKET SHARE, BY KEY PLAYER (2022)
FIGURE 41 SHARE OF LEADING COMPANIES IN GLOBAL THERAPEUTIC RESPIRATORY CARE DEVICES MARKET (2022)
FIGURE 42 SHARE OF LEADING COMPANIES IN GLOBAL MONITORING DEVICES MARKET (2022)
FIGURE 43 SHARE OF LEADING COMPANIES IN GLOBAL DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET (2022)
10.6 COMPANY EVALUATION MATRIX
10.6.1 STARS
10.6.2 EMERGING LEADERS
10.6.3 PERVASIVE PLAYERS
10.6.4 PARTICIPANTS
FIGURE 44 RESPIRATORY CARE DEVICES MARKET: COMPETITIVE LEADERSHIP MATRIX, 2022
10.7 COMPANY EVALUATION MATRIX FOR SMES/START-UPS (2022)
10.7.1 PROGRESSIVE COMPANIES
10.7.2 DYNAMIC COMPANIES
10.7.3 STARTING BLOCKS
10.7.4 RESPONSIVE COMPANIES
FIGURE 45 RESPIRATORY CARE DEVICES MARKET: COMPANY EVALUATION MATRIX FOR SMES/START-UPS, 2022
10.8 COMPETITIVE BENCHMARKING
TABLE 530 RESPIRATORY CARE DEVICES MARKET: KEY STARTUPS/SMES
10.8.1 COMPANY FOOTPRINT
TABLE 531 FOOTPRINT OF COMPANIES, BY OFFERING (25 COMPANIES)
TABLE 532 FOOTPRINT OF COMPANIES, BY DISEASE INDICATION (25 COMPANIES)
TABLE 533 FOOTPRINT OF COMPANIES, BY END USER (25 COMPANIES)
FIGURE 46 OVERALL FOOTPRINT OF COMPANIES (25 COMPANIES)
10.8.2 COMPETITIVE SCENARIOS AND TRENDS
10.8.3 PRODUCT LAUNCHES
TABLE 534 RESPIRATORY CARE DEVICES MARKET: PRODUCT LAUNCHES (2019–2023)
10.8.4 DEALS
TABLE 535 RESPIRATORY CARE DEVICES MARKET: DEALS (2019–2023)
11 COMPANY PROFILES
11.1 KEY PLAYERS
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
11.1.1 KONINKLIJKE PHILIPS N.V.
TABLE 536 KONINKLIJKE PHILIPS N.V.: BUSINESS OVERVIEW
FIGURE 47 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2022)
11.1.2 MEDTRONIC
TABLE 537 MEDTRONIC: BUSINESS OVERVIEW
FIGURE 48 MEDTRONIC: COMPANY SNAPSHOT (2022)
11.1.3 RESMED
TABLE 538 RESMED: BUSINESS OVERVIEW
FIGURE 49 RESMED: COMPANY SNAPSHOT (2022)
11.1.4 MASIMO
TABLE 539 MASIMO: BUSINESS OVERVIEW
FIGURE 50 MASIMO: COMPANY SNAPSHOT (2022)
11.1.5 FISHER & PAYKEL HEALTHCARE LIMITED
TABLE 540 FISHER & PAYKEL HEALTHCARE LIMITED: BUSINESS OVERVIEW
FIGURE 51 FISHER & PAYKEL HEALTHCARE LIMITED: COMPANY SNAPSHOT (2022)
11.1.6 DRÄGERWERK AG & CO. KGAA
TABLE 541 DRÄGERWERK AG & CO. KGAA: BUSINESS OVERVIEW
FIGURE 52 DRÄGERWERK AG & CO. KGAA: COMPANY SNAPSHOT (2022)
11.1.7 GETINGE
TABLE 542 GETINGE: BUSINESS OVERVIEW
FIGURE 53 GETINGE: COMPANY SNAPSHOT (2022)
11.1.8 NIHON KOHDEN CORPORATION
TABLE 543 NIHON KOHDEN CORPORATION: BUSINESS OVERVIEW
FIGURE 54 NIHON KOHDEN CORPORATION: COMPANY SNAPSHOT (2022)
11.1.9 GE HEALTHCARE
TABLE 544 GE HEALTHCARE: BUSINESS OVERVIEW
FIGURE 55 GE HEALTHCARE: COMPANY SNAPSHOT (2022)
11.1.10 VYAIRE MEDICAL, INC.
TABLE 545 VYAIRE MEDICAL, INC.: BUSINESS OVERVIEW
11.1.11 BAXTER INTERNATIONAL, INC.
TABLE 546 BAXTER INTERNATIONAL, INC.: BUSINESS OVERVIEW
FIGURE 56 BAXTER INTERNATIONAL, INC.: COMPANY SNAPSHOT (2022)
11.1.12 ADAPTHEALTH, LLC
TABLE 547 ADAPTHEALTH, LLC: BUSINESS OVERVIEW
FIGURE 57 ADAPTHEALTH, LLC: COMPANY SNAPSHOT (2022)
11.1.13 ROTECH HEALTHCARE, INC.
TABLE 548 ROTECH HEALTHCARE INC.: BUSINESS OVERVIEW
11.1.14 TELEFLEX INCORPORATED
TABLE 549 TELEFLEX INCORPORATED: BUSINESS OVERVIEW
FIGURE 58 TELEFLEX INCORPORATED: COMPANY SNAPSHOT (2022)
11.1.15 AIR LIQUIDE
TABLE 550 AIR LIQUIDE: BUSINESS OVERVIEW
FIGURE 59 AIR LIQUIDE: COMPANY SNAPSHOT (2022)
11.2 OTHER PLAYERS
11.2.1 INVACARE CORPORATION
TABLE 551 INVACARE CORPORATION: BUSINESS OVERVIEW
FIGURE 60 INVACARE CORPORATION: COMPANY SNAPSHOT (2022)
11.2.2 ICU MEDICAL
TABLE 552 ICU MEDICAL: BUSINESS OVERVIEW
FIGURE 61 ICU MEDICAL: COMPANY SNAPSHOT (2022)
11.2.3 HAMILTON MEDICAL AG
TABLE 553 HAMILTON MEDICAL AG: BUSINESS OVERVIEW
11.2.4 APEX MEDICAL CORP
TABLE 554 APEX MEDICAL CORP: BUSINESS OVERVIEW
11.2.5 MEDLINE INDUSTRIES, LP
TABLE 555 MEDLINE INDUSTRIES, LP: BUSINESS OVERVIEW
11.2.6 HUM SOCIETY FOR HOMECARE AND MEDICAL TECHNOLOGY MBH
TABLE 556 HUM SOCIETY FOR HOMECARE AND MEDICAL TECHNOLOGY MBH: BUSINESS OVERVIEW
11.2.7 NONIN
11.2.8 ALLIED MEDICAL LLC
11.2.9 DRIVE DEVILBISS HEALTHCARE
11.2.10 OMRON HEALTHCARE, INC.
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
12 APPENDIX
12.1 DISCUSSION GUIDE
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.3 CUSTOMIZATION OPTIONS
12.4 RELATED REPORTS
12.5 AUTHOR DETAILS
